| | Delaware
|
| 11-2989601 | (State or Other Jurisdiction of Incorporation or Organization) | | 11-2989601 (I.R.S. Employer Identification No.)
|
| | | Terminal Drive
Plainview, New York
| | 11803 | (Address of Principal Executive Offices) | | 11803 (Zip Code)
|
Registrant’s telephone number, including area code: (516) (516) 677-0200
Securities registered pursuant to Section 12(b) of the Act: | | | Title of each class | Trading Symbol(s) | Name of each exchange on which registered | Common Stock, par value $0.01 per share | VECO | The NASDAQ Global Select Market |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x☒ No o◻ Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x.Yes ☒ No o◻ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”filer,” “smaller reporting company”company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. | | | | | Large accelerated filero☒ | | Accelerated filer x
| Non-accelerated filero (Do not check if a smaller reporting company)
| | Accelerated filer ☐ | Non-accelerated filer ☐ | | | | Smaller reporting company o☐ | | | | | Emerging growth company o☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o☐ No x☒ Indicate the numberAs of October 20, 2020, there were 49,612,167 shares outstanding of each of the issuer’s classes ofregistrant’s common stock asoutstanding.
VEECO INSTRUMENTS INC. INDEX Title of Class
|
| Shares Outstanding
| Common Stock
| | as of October 25, 2017
| par value $0.01 per share
| | 48,301,909
|
Safe Harbor Statement This quarterly report on Form 10-Q (the “Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Discussions containing such forward-looking statements may be found in Part I - Items 1, 2, and 3 hereof, as well as within this Report generally. In addition, when used in this Report, the words “believes,” “anticipates,” “expects,” “estimates,���estimates,” “targets,” “plans,” “intends,” “will,” and similar expressions related to the future are intended to identify forward-looking statements. All forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from projected results. In addition, the preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates and assumptions are based on knowledge of current events, including the potential impact of the COVID-19 pandemic on our business, and planned actions to be undertaken in the future, they may ultimately differ from actual results. Operating results for the three and nine months ended September 30, 20172020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017. 2020. All estimates and assumptions are subject to a number of risks and uncertainties that could cause actual results to differ materially from these estimates and assumptions. The risks and uncertainties of Veeco Instruments Inc. (together with its consolidated subsidiaries, “Veeco,” the “Company,” “we,” “us,” and “our,” unless the context indicates otherwise) include, without limitation, those set forth under the following: · Unfavorable market conditions may adversely affectheading “Risk Factors” Part 1, Item 1A in our operating results;
· A reduction or elimination of foreign government subsidies2019 Form 10-K, and economic incentives may adversely affect the future order rate for our MOCVD equipment;
· The cyclicality of the industries we serve directly affects our business;
· We operate in industries characterized by rapid technological change;
· We have a concentrated customer base, located primarily in a limited number of regions, which operate in highly concentrated industries;
· We face significant competition;
· The timingPart 2, Item 1A of our orders, shipments,quarterly reports on Form 10-Q for the quarters ended March 31, 2020 and revenue recognition may cause our quarterly operating results to fluctuate significantly;June 30, 2020, and the following:
| ● | The unknown duration and economic, operational, and financial impacts of the COVID-19 pandemic and the actions taken or contemplated by governmental authorities or others in response to the pandemic on our business, employees, customers and suppliers, including, among others, (a) changes in customer demand for our products, (b) disruptions in our supply chain, particularly to the extent we rely on a single supplier for certain components, (c) financial challenges confronting major customers in light of reduced end-user demand for their products, (d) operational changes implemented by us, including remote working arrangements, which may put increased strain on our IT systems and create increased vulnerability to cybersecurity incidents, (e) increases in shipping, raw material or other costs, (f) competitive pricing pressures, and (g) prolonged measures to contain the spread of COVID-19 or the premature easing of government-imposed restrictions implemented to contain the spread of COVID-19; |
· Our sales cycle is long and unpredictable;
| ● | Unfavorable market conditions have adversely affected, and may continue to adversely affect, our operating results; |
| ● | We are exposed to the risks of operating a global business; |
· Our backlog is subject to customer cancellation or modification which could result in decreased sales, increased inventory obsolescence, and/or liabilities to our suppliers for products no longer needed;
| ● | Changes in U.S. trade policy and export controls and ongoing trade disputes between the U.S. and China have adversely affected, and may continue to adversely affect, our business, results of operations, and financial condition; |
| ● | Disruptions in our information technology systems or data security incidents could result in significant financial, legal, regulatory, business, and reputational harm to us; |
· Our failure to estimate customer demand accurately could result in inventory obsolescence, liabilities to our suppliers for products no longer needed, and/or manufacturing interruptions or delays which could affect our ability to meet customer demand;
| ● | We may be unable to effectively enforce and protect our intellectual property rights; |
| ● | We may be subject to claims of intellectual property infringement by others; |
· Our failure to successfully manage our outsourcing activities or failure
| ● | We face significant competition; |
| ● | We operate in industries characterized by rapid technological change; |
| ● | Certain of our sales are dependent on the demand for consumer electronics, which can experience significant volatility due to seasonal and other factors; |
| ● | We have a concentrated customer base, located primarily in a limited number of regions, which operates in highly concentrated industries; |
| ● | The cyclicality of the industries we serve directly affects our business; |
| ● | The timing of our orders, shipments, and revenue recognition may cause our quarterly operating results to fluctuate significantly; |
| ● | Our sales cycle is long and unpredictable; |
| ● | Our backlog is subject to customer cancellation or modification which could result in decreased sales, increased inventory obsolescence, and liabilities to our suppliers for products no longer needed; |
| ● | We may be unable to obtain required export licenses for the sale of our products; |
| ● | Our operating results may be adversely affected by tightening credit markets; |
| ● | Our failure to estimate customer demand accurately could result in inventory obsolescence, liabilities to our suppliers for products no longer needed, and manufacturing interruptions or delays which could affect our ability to meet customer demand; |
| ● | Our failure to successfully manage our outsourcing activities or failure of our outsourcing partners to perform as anticipated could adversely affect our results of operations; |
| ● | We rely on a limited number of suppliers, some of whom are our sole source for particular components; |
| ● | The price of our common shares is volatile and could decrease; |
| ● | We may be required to take impairment charges on assets; |
| ● | Our inability to attract, retain, and motivate employees could have a material adverse effect on our business; |
| ● | We are exposed to risks associated with business combinations, acquisitions, strategic investments and divestitures; |
| ● | We are subject to internal control evaluations and attestation requirements of Section 404 of the Sarbanes-Oxley Act and any delays or difficulties in satisfying these requirements or negative reports concerning our internal controls could adversely affect our future results of operations and our stock price; |
| ● | Changes in accounting pronouncements or taxation rules or practices may adversely affect our financial results; |
| ● | Our income taxes may change; |
| ● | We have indebtedness in the form of convertible senior notes which could adversely affect our financial position, prevent us from implementing our strategy, and dilute the ownership interest of our existing shareholders; |
| ● | The accounting method for convertible debt securities that may be settled in cash, such as the 2023 and 2027 Notes, could have a material effect on our reported financial results; |
| ● | The effects of the capped call transactions that we entered in connection with the issuance of the convertible senior notes due 2027, which may include changes in the value of the notes and our common stock; |
· We rely on a limited number of suppliers, some of whom are our sole source for particular components;
| ● | We are subject to foreign currency exchange risks; |
| ● | We have adopted certain measures that may have anti-takeover effects which may make an acquisition of our Company by another company more difficult; |
· Our inability to attract, retain, and motivate employees could have a material adverse effect on our business;
| ● | We are exposed to various risks associated with global regulatory requirements; |
| ● | We may be exposed to liabilities under the Foreign Corrupt Practices Act and other similar laws; |
· Our acquisition strategy subjects us to risks associated with evaluating and pursuing these opportunities and integrating these businesses;
| ● | We are subject to risks of non-compliance with environmental, health, and safety regulations; and |
| ● | We have significant operations in locations which could be materially and adversely impacted in the event of a natural disaster, an act of terrorism, or other significant disruption. |
· Timing of market adoption of LED technology for general lighting is uncertain;
· Our sales to manufacturers are highly dependent on sales of consumer electronics applications, which can experience significant volatility due to seasonal and other factors and materially adversely impact our future results of operations;
· Our operating results have been, and may continue to be, adversely affected by tightening credit markets;
· We are exposed to the risks of operating a global business, including the need to obtain export licenses for certain of our shipments and political risks in the countries we operate;
· We may be exposed to liabilities under the Foreign Corrupt Practices Act and any determination that we violated these or similar laws could have a material adverse effect on our business;
· We are subject to internal control evaluations and attestation requirements of Section 404 of the Sarbanes-Oxley Act and any delays or difficulty in satisfying these requirements or negative reports concerning our internal controls could adversely affect our future results of operations and our stock price;
· Changes in accounting pronouncements or taxation rules or practices may adversely affect our financial results;
· Our income taxes can change;
· We may be required to take additional impairment charges on assets;
· We have indebtedness in the form of convertible senior notes which could adversely affect our financial position, prevent us from implementing our strategy, and dilute the ownership interest of our existing shareholders;
· The accounting method for convertible debt securities that may be settled in cash, such as the Convertible Senior Notes, could have a material effect on our reported financial results;
· The price of our common shares is volatile and could decline significantly;
· The enforcement and protection of our intellectual property rights may be expensive and/or divert our limited resources;
· We may be subject to claims of intellectual property infringement by others;
· We are subject to foreign currency exchange risks;
· If we are subject to cyber-attacks we could incur substantial costs and, if such attacks are successful, we could incur significant liabilities, reputational harm, and disruption to our operations;
· We have adopted certain measures that may have anti-takeover effects which may make an acquisition of our Company by another company more difficult;
· We are subject to risks of non-compliance with environmental, health, and safety regulations;
· Regulations related to conflict minerals will force us to incur additional expenses, may make our supply chain more complex, and may result in damage to our relationships with customers;
· We have significant operations in locations which could be materially and adversely impacted in the event of a natural disaster, an act of terrorism or other significant disruption; and
· We may not be able to successfully integrate the business of Ultratech with our own or realize the anticipated benefits of the merger.
Consequently, such forward looking statements and estimates should be regarded solely as the current plans and beliefs of Veeco. We do not undertake any obligation to update any forward looking statements to reflect future events or circumstances after the date of such statements. PART I—I—FINANCIAL INFORMATION Item 1. Financial Statements Veeco Instruments Inc. and Subsidiaries Consolidated Balance Sheets (in thousands, except share amounts) | | | | | | | | | September 30, | | December 31, | | | 2020 | | 2019 | | | (unaudited) | | | | Assets | | | | | | Current assets: | | | | | | | Cash and cash equivalents | | $ | 147,588 | | $ | 129,294 | Restricted cash | | | 664 | | | 657 | Short-term investments | | | 161,585 | | | 115,252 | Accounts receivable, net | | | 80,212 | | | 45,666 | Contract assets | | | 21,342 | | | 25,351 | Inventories | | | 143,469 | | | 133,067 | Deferred cost of sales | | | 1,677 | | | 445 | Prepaid expenses and other current assets | | | 15,948 | | | 14,966 | Assets held for sale | | | — | | | 11,180 | Total current assets | | | 572,485 | | | 475,878 | Property, plant, and equipment, net | | | 65,811 | | | 75,711 | Operating lease right-of-use assets | | | 10,522 | | | 14,453 | Intangible assets, net | | | 50,016 | | | 61,518 | Goodwill | | | 181,943 | | | 181,943 | Deferred income taxes | | | 1,555 | | | 1,549 | Other assets | | | 7,293 | | | 7,036 | Total assets | | $ | 889,625 | | $ | 818,088 | | | | | | | | Liabilities and stockholders' equity | | | | | | | Current liabilities: | | | | | | | Accounts payable | | $ | 33,837 | | $ | 21,281 | Accrued expenses and other current liabilities | | | 40,667 | | | 41,243 | Customer deposits and deferred revenue | | | 71,539 | | | 54,870 | Income taxes payable | | | 891 | | | 830 | Total current liabilities | | | 146,934 | | | 118,224 | Deferred income taxes | | | 5,984 | | | 5,648 | Long-term debt | | | 320,818 | | | 300,068 | Operating lease long-term liabilities | | | 6,793 | | | 10,300 | Other liabilities | | | 11,003 | | | 9,336 | Total liabilities | | | 491,532 | | | 443,576 | Stockholders' equity: | | | | | | | Preferred stock, $0.01 par value; 500,000 shares authorized; 0 shares issued and outstanding. | | | — | | | — | Common stock, $0.01 par value; 120,000,000 shares authorized; 49,612,167 shares issued and outstanding at September 30, 2020 and 48,994,346 shares issued and outstanding at December 31, 2019 | | | 496 | | | 490 | Additional paid-in capital | | | 1,102,959 | | | 1,071,058 | Accumulated deficit | | | (707,219) | | | (698,930) | Accumulated other comprehensive income | | | 1,857 | | | 1,894 | Total stockholders' equity | | | 398,093 | | | 374,512 | Total liabilities and stockholders' equity | | $ | 889,625 | | $ | 818,088 |
| | September 30, | | December 31, | | | | 2017 | | 2016 | | | | (unaudited) | | | | Assets | | | | | | Current assets: | | | | | | Cash and cash equivalents | | $ | 235,268 | | $ | 277,444 | | Short-term investments | | 85,853 | | 66,787 | | Accounts receivable, net | | 113,795 | | 58,020 | | Inventories | | 113,681 | | 77,063 | | Deferred cost of sales | | 17,594 | | 6,160 | | Prepaid expenses and other current assets | | 36,396 | | 16,034 | | Total current assets | | 602,587 | | 501,508 | | Property, plant and equipment, net | | 84,403 | | 60,646 | | Intangible assets, net | | 383,596 | | 58,378 | | Goodwill | | 308,529 | | 114,908 | | Deferred income taxes | | 2,528 | | 2,045 | | Other assets | | 25,263 | | 21,047 | | Total assets | | $ | 1,406,906 | | $ | 758,532 | | | | | | | | Liabilities and stockholders’ equity | | | | | | Current liabilities: | | | | | | Accounts payable | | $ | 53,716 | | $ | 22,607 | | Accrued expenses and other current liabilities | | 65,728 | | 33,201 | | Customer deposits and deferred revenue | | 107,636 | | 85,022 | | Income taxes payable | | 4,171 | | 2,311 | | Current portion of long-term debt | | — | | 368 | | Total current liabilities | | 231,251 | | 143,509 | | Deferred income taxes | | 46,268 | | 13,199 | | Long-term debt | | 272,825 | | 826 | | Other liabilities | | 11,033 | | 6,403 | | Total liabilities | | 561,377 | | 163,937 | | Stockholders’ equity: | | | | | | Preferred stock, $0.01 par value; 500,000 shares authorized; no shares issued and outstanding | | — | | — | | Common stock, $0.01 par value; 120,000,000 shares authorized; 48,294,284 and 40,714,790 shares issued at September 30, 2017 and December 31, 2016, respectively; 48,294,284 and 40,588,194 shares outstanding at September 30, 2017 and December 31, 2016, respectively. | | 483 | | 407 | | Additional paid-in capital | | 1,050,994 | | 763,303 | | Accumulated deficit | | (207,760 | ) | (168,583 | ) | Accumulated other comprehensive income | | 1,812 | | 1,777 | | Treasury stock, at cost, 126,596 shares at December 31, 2016. | | — | | (2,309 | ) | Total stockholders’ equity | | 845,529 | | 594,595 | | Total liabilities and stockholders’ equity | | $ | 1,406,906 | | $ | 758,532 | |
See accompanying Notes to the Consolidated Financial Statements.Statements. Veeco Instruments Inc. and Subsidiaries Consolidated Statements of Operations (in thousands, except per share amounts) (unaudited) | | Three months ended September 30, | | Nine months ended September 30, | | | | 2017 | | 2016 | | 2017 | | 2016 | | Net sales | | $ | 131,872 | | $ | 85,482 | | $ | 341,324 | | $ | 238,842 | | Cost of sales | | 78,811 | | 52,027 | | 215,344 | | 141,991 | | Gross profit | | 53,061 | | 33,455 | | 125,980 | | 96,851 | | Operating expenses, net: | | | | | | | | | | Research and development | | 24,061 | | 19,892 | | 57,669 | | 63,545 | | Selling, general, and administrative | | 29,771 | | 18,396 | | 71,574 | | 58,230 | | Amortization of intangible assets | | 12,500 | | 5,261 | | 21,722 | | 15,785 | | Restructuring | | 5,010 | | 1,798 | | 9,605 | | 3,993 | | Acquisition costs | | 783 | | — | | 16,277 | | — | | Asset impairment | | 2 | | 56,035 | | 1,139 | | 69,662 | | Other, net | | (140 | ) | 795 | | (228 | ) | 884 | | Total operating expenses, net | | 71,987 | | 102,177 | | 177,758 | | 212,099 | | Operating income (loss) | | (18,926 | ) | (68,722 | ) | (51,778 | ) | (115,248 | ) | Interest income | | 357 | | 283 | | 1,933 | | 879 | | Interest expense | | (5,105 | ) | (23 | ) | (14,301 | ) | (166 | ) | Income (loss) before income taxes | | (23,674 | ) | (68,462 | ) | (64,146 | ) | (114,535 | ) | Income tax expense (benefit) | | (1,790 | ) | 1,136 | | (24,969 | ) | 2,677 | | Net income (loss) | | $ | (21,884 | ) | $ | (69,598 | ) | $ | (39,177 | ) | $ | (117,212 | ) | | | | | | | | | | | Income (loss) per common share: | | | | | | | | | | Basic | | $ | (0.47 | ) | $ | (1.78 | ) | $ | (0.91 | ) | $ | (2.99 | ) | Diluted | | $ | (0.47 | ) | $ | (1.78 | ) | $ | (0.91 | ) | $ | (2.99 | ) | | | | | | | | | | | Weighted average number of shares: | | | | | | | | | | Basic | | 46,941 | | 39,131 | | 43,100 | | 39,193 | | Diluted | | 46,941 | | 39,131 | | 43,100 | | 39,193 | |
See accompanying Notes to the Consolidated Financial Statements.
Veeco Instruments Inc. and Subsidiaries
Consolidated Statements of Comprehensive Income (Loss)
(in thousands)
(unaudited)
| | Three months ended September 30, | | Nine months ended September 30, | | | | 2017 | | 2016 | | 2017 | | 2016 | | Net income (loss) | | $ | (21,884 | ) | $ | (69,598 | ) | $ | (39,177 | ) | $ | (117,212 | ) | Other comprehensive income, net of tax | | | | | | | | | | Unrealized gain (loss) on available-for-sale securities | | 70 | | (7 | ) | 10 | | 32 | | Minimum pension liability | | — | | 866 | | — | | 866 | | Foreign currency translation | | 1 | | (7 | ) | 25 | | 20 | | Total other comprehensive income, net of tax | | 71 | | 852 | | 35 | | 918 | | | | | | | | | | | | Comprehensive income (loss) | | $ | (21,813 | ) | $ | (68,746 | ) | $ | (39,142 | ) | $ | (116,294 | ) |
See accompanying Notes to the Consolidated Financial Statements.
| | | | | | | | | | | | | | | | Three months ended September 30, | | Nine months ended September 30, | | | | 2020 | | 2019 | | 2020 | | 2019 | | Net sales | | $ | 112,078 | | $ | 108,954 | | $ | 315,216 | | $ | 306,147 | | Cost of sales | | | 62,936 | | | 66,731 | | | 177,761 | | | 192,924 | | Gross profit | | | 49,142 | | | 42,223 | | | 137,455 | | | 113,223 | | Operating expenses, net: | | | | | | | | | | | | | | Research and development | | | 19,129 | | | 22,639 | | | 57,577 | | | 68,901 | | Selling, general, and administrative | | | 19,415 | | | 20,962 | | | 55,541 | | | 60,620 | | Amortization of intangible assets | | | 3,831 | | | 4,312 | | | 11,502 | | | 12,773 | | Restructuring | | | — | | | 1,828 | | | 1,097 | | | 3,874 | | Asset impairment | | | — | | | — | | | 281 | | | — | | Other operating expense (income), net | | | (218) | | | (153) | | | (502) | | | (232) | | Total operating expenses, net | | | 42,157 | | | 49,588 | | | 125,496 | | | 145,936 | | Operating income (loss) | | | 6,985 | | | (7,365) | | | 11,959 | | | (32,713) | | Interest income | | | 231 | | | 1,219 | | | 1,458 | | | 3,749 | | Interest expense | | | (6,425) | | | (5,549) | | | (18,131) | | | (16,491) | | Loss on extinguishment of debt | | | — | | | — | | | (3,046) | | | — | | Income (loss) before income taxes | | | 791 | | | (11,695) | | | (7,760) | | | (45,455) | | Income tax expense (benefit) | | | 211 | | | 72 | | | 530 | | | 407 | | Net income (loss) | | $ | 580 | | $ | (11,767) | | $ | (8,290) | | $ | (45,862) | | | | | | | | | | | | | | | | Income (loss) per common share: | | | | | | | | | | | | | | Basic | | $ | 0.01 | | $ | (0.25) | | $ | (0.17) | | $ | (0.97) | | Diluted | | $ | 0.01 | | $ | (0.25) | | $ | (0.17) | | $ | (0.97) | | | | | | | | | | | | | | | | Weighted average number of shares: | | | | | | | | | | | | | | Basic | | | 48,341 | | | 47,489 | | | 48,327 | | | 47,361 | | Diluted | | | 49,174 | | | 47,489 | | | 48,327 | | | 47,361 | |
Veeco Instruments Inc. and Subsidiaries
Consolidated Statements of Cash Flows
(in thousands)
(unaudited)
| | Nine months ended September 30, | | | | 2017 | | 2016 | | Cash Flows from Operating Activities | | | | | | Net income (loss) | | $ | (39,177 | ) | $ | (117,212 | ) | Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | | | | | | Depreciation and amortization | | 32,295 | | 26,010 | | Non-cash interest expense | | 7,641 | | — | | Deferred income taxes | | (21,235 | ) | 1,529 | | Share-based compensation expense | | 19,976 | | 12,133 | | Asset impairment | | 1,139 | | 69,662 | | Provision for bad debts | | 99 | | 160 | | Changes in operating assets and liabilities: | | | | | | Accounts receivable | | (10,409 | ) | (1,184 | ) | Inventories and deferred cost of sales | | 9,486 | | (10,909 | ) | Prepaid expenses and other current assets | | (331 | ) | 3,661 | | Accounts payable and accrued expenses | | 3,165 | | (13,995 | ) | Customer deposits and deferred revenue | | 17,779 | | 3,568 | | Income taxes receivable and payable, net | | (16 | ) | — | | Long-term income tax liability | | (4,877 | ) | 80 | | Other, net | | (259 | ) | 2,189 | | Net cash provided by (used in) operating activities | | 15,276 | | (24,308 | ) | | | | | | | Cash Flows from Investing Activities | | | | | | Acquisitions of businesses, net of cash acquired | | (399,478 | ) | — | | Capital expenditures | | (17,403 | ) | (10,717 | ) | Proceeds from the sale of investments | | 307,757 | | 131,297 | | Payments for purchases of investments | | (279,945 | ) | (78,376 | ) | Proceeds from held for sale assets | | 2,284 | | 693 | | Other | | — | | (230 | ) | Net cash provided by (used in) investing activities | | (386,785 | ) | 42,667 | | | | | | | | Cash Flows from Financing Activities | | | | | | Proceeds (net of tax withholdings) from option exercises and employee stock purchase plan | | 2,546 | | 1,192 | | Restricted stock tax withholdings | | (7,797 | ) | (1,184 | ) | Purchases of common stock | | — | | (13,349 | ) | Proceeds from long-term debt borrowings | | 335,752 | | — | | Principal payments on long-term debt | | (1,193 | ) | (252 | ) | Net cash provided by (used in) financing activities | | 329,308 | | (13,593 | ) | | | | | | | Effect of exchange rate changes on cash and cash equivalents | | 25 | | 20 | | Net increase (decrease) in cash and cash equivalents | | (42,176 | ) | 4,786 | | Cash and cash equivalents - beginning of period | | 277,444 | | 269,232 | | | | $ | 235,268 | | $ | 274,018 | | | | | | | | Supplemental Disclosure of Cash Flow Information | | | | | | Interest paid | | $ | 4,667 | | $ | 179 | | Income taxes paid | | 1,767 | | 1,456 | | Non-cash operating and financing activities | | | | | | Net transfer of inventory to property, plant and equipment | | 33 | | — | |
See accompanying Notes to the Consolidated Financial Statements. Veeco Instruments Inc. and Subsidiaries Consolidated Statements of Comprehensive Income (Loss) (in thousands) (unaudited) | | | | | | | | | | | | | | | | Three months ended September 30, | | Nine months ended September 30, | | | | 2020 | | 2019 | | 2020 | | 2019 | | Net income (loss) | | $ | 580 | | $ | (11,767) | | $ | (8,290) | | $ | (45,862) | | Other comprehensive income (loss), net of tax: | | | | | | | | | | | | | | Unrealized gain (loss) on available-for-sale securities | | | (69) | | | (38) | | | (16) | | | 8 | | Foreign currency translation gain (loss) | | | 9 | | | (4) | | | (21) | | | 8 | | Total other comprehensive income (loss), net of tax | | | (60) | | | (42) | | | (37) | | | 16 | | | | | | | | | | | | | | | | Total comprehensive income (loss) | | $ | 520 | | $ | (11,809) | | $ | (8,327) | | $ | (45,846) | |
See accompanying Notes to the Consolidated Financial Statements. Veeco Instruments Inc. and Subsidiaries Consolidated Statements of Cash Flows (in thousands) (unaudited) | | | | | | | | | | Nine months ended September 30, | | | | 2020 | | 2019 | | Cash Flows from Operating Activities | | | | | | | | Net income (loss) | | $ | (8,290) | | $ | (45,862) | | Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | | | | | | | | Depreciation and amortization | | | 23,021 | | | 25,838 | | Non-cash interest expense | | | 10,282 | | | 9,418 | | Deferred income taxes | | | 330 | | | 20 | | Share-based compensation expense | | | 9,562 | | | 11,528 | | Loss on extinguishment of debt | | | 3,046 | | | — | | Asset impairment | | | 281 | | | — | | Provision for bad debts | | | 140 | | | — | | Changes in operating assets and liabilities: | | | | | | | | Accounts receivable and contract assets | | | (30,677) | | | (16,308) | | Inventories and deferred cost of sales | | | (10,336) | | | 17,921 | | Prepaid expenses and other current assets | | | (982) | | | (1,276) | | Accounts payable and accrued expenses | | | 11,130 | | | (16,000) | | Customer deposits and deferred revenue | | | 16,728 | | | (6,705) | | Income taxes receivable and payable, net | | | 61 | | | (593) | | Other, net | | | 3,295 | | | (986) | | Net cash provided by (used in) operating activities | | | 27,591 | | | (23,005) | | | | | | | | | | Cash Flows from Investing Activities | | | | | | | | Capital expenditures | | | (3,331) | | | (8,189) | | Proceeds from the sale of investments | | | 139,531 | | | 102,230 | | Payments for purchases of investments | | | (185,576) | | | (148,664) | | Proceeds from held for sale assets, net of costs to sell | | | 9,503 | | | 645 | | Net cash provided by (used in) investing activities | | | (39,873) | | | (53,978) | | | | | | | | | | Cash Flows from Financing Activities | | | | | | | | Proceeds from issuance of 2027 Notes, net of issuance costs | | | 121,946 | | | — | | Purchase of capped calls | | | (10,313) | | | — | | Repurchase of 2023 Notes | | | (81,240) | | | — | | Proceeds (net of tax withholdings) from option exercises and employee stock purchase plan | | | 2,428 | | | 2,609 | | Restricted stock tax withholdings | | | (2,217) | | | (2,771) | | Net cash provided by (used in) financing activities | | | 30,604 | | | (162) | | Effect of exchange rate changes on cash and cash equivalents | | | (21) | | | 9 | | Net increase (decrease) in cash, cash equivalents, and restricted cash | | | 18,301 | | | (77,136) | | Cash, cash equivalents, and restricted cash - beginning of period | | | 129,951 | | | 213,082 | | Cash, cash equivalents, and restricted cash - end of period | | $ | 148,252 | | $ | 135,946 | | | | | | | | | | Supplemental Disclosure of Cash Flow Information | | | | | | | | Interest paid | | $ | 8,989 | | $ | 9,401 | | Income taxes paid | | | 248 | | | 2,835 | | Non-cash operating and financing activities | | | | | | | | Net transfer of property, plant and equipment to inventory | | | 1,624 | | | 4,074 | | Right-of-use assets obtained in exchange for lease obligations | | | 951 | | | 516 | |
See accompanying Notes to the Consolidated Financial Statements. Table of Contents Veeco Instruments Inc. and Subsidiaries Notes to the Consolidated Financial Statements (unaudited) Note 1 -— Basis of Presentation The accompanying unaudited Consolidated Financial Statements of Veeco have been prepared in accordance with U.S. GAAP as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 270 for interim financial information and with the instructions to Rule 10-01 of Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements as the interim information is an update of the information that was presented in Veeco’s most recent annual financial statements. For further information, refer to Veeco’s Consolidated Financial Statements and Notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 20162019 (“20162019 Form 10-K”). In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal, recurring nature. Certain amounts previously reported have been reclassified in the financial statements to conform to the current presentation. Veeco reports interim quarters on a 13-week basis ending on the last Sunday of each quarter. The fourth quarter always ends on the last day of the calendar year, December 31. The 2017 interim quarters end on April 2, July 2, and October 1, and the 20162020 interim quarters ended on April 3, July 3,March 29, June 28, and October 2.September 27, and the 2019 interim quarters ended on March 31, June 30, and September 29. These interim quarters are reported as March 31, June 30, and September 30 in Veeco’s interim consolidated financial statements. Revenue recognition
Veeco recognizes revenue when allThe preparation of financial statements in conformity with U.S GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, actual results may differ from these estimates. In particular, the COVID-19 pandemic has adversely impacted and is likely to further adversely impact the Company’s business and markets, including the Company’s workforce and operations and the operations of the following criteria have been met: persuasive evidenceCompany’s customers, suppliers, and business partners. The full extent to which the pandemic will directly or indirectly impact the Company's business, results of an arrangement exists with a customer; deliveryoperations and financial condition, including sales, expenses, manufacturing, research and development costs, reserves and allowances, fair value measurements, and asset impairment charges, will depend on future developments that are highly uncertain and difficult to predict. These developments include, but are not limited to, the duration and spread of the specified products has occurredoutbreak, its severity, the actions to contain the virus or services have been rendered; prices are contractually fixed or determinable;address its impact, governmental actions to contain the spread of the pandemic and collectability is reasonably assured. respond to the reduction in global economic activity, and how quickly and to what extent normal economic and operating conditions can resume.
Revenue Recognition Revenue is recorded including shippingrecognized upon the transfer of control of the promised product or service to the customer in an amount that reflects the consideration the Company expects to receive in exchange for such product or service. The Company’s contracts with customers generally do not contain variable consideration. In the rare instances where variable consideration is included, the Company estimates the amount of variable consideration and handling costsdetermines what portion of that, if any, has a high probability of significant subsequent revenue reversal, and excluding applicable taxes related to sales. Contractsif so, that amount is excluded from the transaction price. The Company’s contracts with customers frequently contain multiple deliverables,, such as systems, upgrades, components, spare parts, installation, maintenance, and service plans.plans. Judgment is required to properly identify the accounting units of the multiple-element arrangementsperformance obligations within a contract and to determine how the revenue should be allocated among the accounting units. Veecoperformance obligations. The Company also evaluates whether multiple transactions with the same customer or related parties should be considered part of a single multiple-element arrangementcontract based on an assessment of whether the contracts or agreements are negotiated or executed within a short time frame of each other or if there are indicators that the contracts are negotiated in contemplation of one another. Moreover, judgment is used in interpreting the commercial terms and determining when all criteria have been met in order to recognize revenue in the appropriate accounting period.
When there are separate units of accounting, Veecothe Company allocates revenue to each elementperformance obligation on a relative stand-alone selling price basis. The stand-alone selling prices are determined based on the following selling price hierarchy: vendor-specific objective evidence (“VSOE”) if available; third party evidence (“TPE”) if VSOE is not available; orprices at which the best estimateCompany separately sells the systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items that isare not contingent uponsold separately, the delivery of additional items.Company estimates stand-alone selling prices generally using an expected cost plus margin approach. VeecoMost of the Company’s revenue is recognized at a point in time when the performance obligation is satisfied. The Company considers many facts when evaluating each of its sales arrangements to determine the timing of revenue recognition, including its contractual obligations the customer’s creditworthiness, and the nature of the customer’s post-delivery acceptance provisions. Veeco’sThe Company’s system sales arrangements, including certain upgrades, generally include field acceptance provisions that may include functional or mechanical test procedures. For the majoritymany of thethese arrangements, a customer source inspection of the system is performed in Veeco’sthe Company’s facility, or test data is sent to the customer documenting that the system is functioning to the agreed upon specifications prior to delivery.delivery, or other quality assurance testing is performed internally to ensure system functionality prior to shipment. Historically, such source inspection or test data replicates the field acceptance provisions that are performed at the customer’s site prior to final acceptance of the system. When Veecothe Company objectively demonstrates that the criteria specified in the contractual acceptance provisions are achieved prior to delivery either through customer testing or the Company’s historical experience of its tools meeting specifications, transfer of control of the product to the customer is considered to have occurred and revenue is recognized upon system delivery since there is no substantive contingency remaining related to the acceptance provisions at that date, subject to the retention amount constraint described below for certain contracts.date. For new products, new applications of existing products, or for products with substantive customer acceptance provisions where Veecothe Company cannot objectively demonstrate that the criteria specified in the contractual acceptance provisions have been achieved prior to delivery, revenue and the associated costs are deferreddeferred. The Company recognizes such revenue and fully recognizedcosts upon obtaining objective evidence that the receipt of customer acceptance provisions can be achieved, assuming all other revenue recognition criteria have been met.
The Company’s system sales arrangements, including certain upgrades, generally do not contain provisions for the right of return, forfeiture, refund, or other purchase price concession. In the rare instances where such provisions are included, all revenue is deferred until such rights expire. The sales arrangements generally include installation. The installation process is not deemed essential to the functionality of the equipment since it is not complex; it does not require significant changes to the features or capabilities of the equipment or involve constructing elaborate interfaces or connections subsequent to factory acceptance. Veeco has a demonstrated history of consistently completing installations in a timely manner and can reliably estimate the costs of such activities. Most customers engage Veeco to perform the installation services, although there are other third-party providers with sufficient knowledge who could complete these services. Based on these factors, installation is deemed to be inconsequential or perfunctory relative to the system sale as a whole, and as a result, installation service is not considered a separate element of the arrangement. As such, Veeco records the cost of the installation at the earlier of the time of revenue recognition for the system or when installation services are performed.
In certain cases Veeco’s products are soldthe Company’s contracts with customers contain a billing retention, typically 10% of the sales price, which is billed by Veecothe Company and payable by the customer when field acceptance provisions are completed. The amountRevenue recognized in advance of revenue recognized upon delivery of a system or upgrade, if any, is limited to the lower of i) the amount that has been billed that is not contingent upon acceptance provisions or ii)recorded as a contract asset on the value of the arrangement consideration allocated to the delivered elements, if such sale is part of a multiple-element arrangement.Consolidated Balance Sheets. The Company recognizes revenue related to maintenance and service contracts ratably over time based upon the applicablerespective contract term. VeecoInstallation revenue is recognized over time as the installation services are performed. The Company recognizes revenue from the sales of components, spare parts, and specified service engagements at a point in time, which is typically consistent with the time of delivery in accordance with the terms of the applicable sales arrangement. The Company may receive customer deposits on system transactions. The timing of the transfer of goods or services related to the deposits is either at the discretion of the customer or expected to be within one year from the deposit receipt. As such, the Company does not adjust transaction prices for the time value of money. Incremental direct costs incurred related to the acquisition of a customer contract, such as sales commissions, are expensed as incurred even ifsince the related revenueexpected amortization period is deferred in accordance with the above policy.one year or less. Recent accounting pronouncements
The FASB issued ASU 2014-09, as amended: Revenue from Contracts with Customers, which has been codified as Accounting Standards Codification 606 (“ASC 606”). ASC 606 requires the Company’s revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which it expects to be entitled in exchange for those goods or services. ASC 606 outlines a five-step model to make the revenue recognition determination and requires new financial statement disclosures. Publicly-traded companies are required to adopt ASC 606 for reporting periods beginning after December 15, 2017. The Company is still completing its evaluation of the impact of adopting this standard; however, the Company currently expects the most significant financial statement impacts of adopting ASC 606 will be the elimination of the constraint on revenue associated with the billing retention relatedhas elected to the receipt of customer final acceptance as well as the identification of installation servicestreat shipping and handling costs as a performance obligation. The elimination of the constraint on revenue related to customer final acceptance, which is usually about 10 percent of a system sale, will generally be recognized at the time the Company transfers control of the system to the customer, which is earlier than under the Company’s current revenue recognition model for certain contracts that are subject to the billing retention constraint described above. The new performance obligation related to installation services under the new standard will generally be recognized as the installation services are performed, which is later than under the Company’s current revenue recognition model. Taken together, the Company currently believes there will be a net acceleration of a small percentage of its revenue under ASC 606 as compared to its current revenue recognition model. ASC 606 provides for different transition alternatives,fulfillment activity, and the Company includes such costs in cost of services when the Company recognizes revenue for the related goods. Taxes assessed by governmental authorities that are collected by the Company from a customer are excluded from revenue.
Inventories Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Each quarter the Company assesses the valuation and recoverability of all inventories: materials (raw materials, spare parts, and service inventory); work-in-process; and finished goods. Obsolete inventory or inventory in excess of management’s estimated usage requirement is evaluatingwritten down to its estimated net realizable value if less than cost. The Company evaluates usage requirements by analyzing historical usage, anticipated demand, alternative uses of materials, and other qualitative factors. Unanticipated changes in demand for the Company’s products may require a write down of Table of Contents Veeco Instruments Inc. and Subsidiaries Notes to the Consolidated Financial Statements - continued (unaudited) inventory, which methodwould be reflected in cost of adoption to select.sales in the period the revision is made. Inventory acquired as part of a business combination is recorded at fair value on the date of acquisition. Recently Adopted Accounting Standards In January 2016,December 2019, the FASB issued ASU 2016-01:2019-12: Financial Instruments — OverallIncome Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which requires. This standard simplifies the accounting for income taxes by eliminating certain equity investmentsexceptions to be measured at fair value, withthe general principles and simplifying several aspects of ASC 740, Income taxes, including, but not limited to, requirements related to the following: a) exception to the incremental approach for intraperiod tax allocation; b) the tax basis step-up in goodwill obtained in a transaction that is not a business combination; c) ownership changes in fair value recognizedinvestments - changes from a subsidiary to an equity method investment; d) separate financial statements of entities not subject to tax; e) interim-period accounting for enacted changes in net income. Publicly-traded companies are required to adopttax law; and f) the update for reporting periodsyear-to-date loss limitation in interim-period tax accounting. As permitted by ASU 2019-12, the Company early-adopted this standard in the second quarter of 2020, effective as of the beginning after December 15, 2017; earlyof fiscal year 2020. The adoption is permitted. The Company doesdid not expect this ASU will have a material impact on the Company’s consolidated financial statements.statements as of the date of adoption. Recent Accounting Standards Not Yet Adopted In February 2016,August 2020, the FASB issued ASU 2016-02:2020-06: LeasesDebt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which generally. This standard simplifies the accounting for convertible debt instruments by removing the separation models for convertible debt with a cash conversion feature, as well as convertible instruments with a beneficial conversion feature. As a result, entity’s will account for a convertible debt instrument wholly as debt, unless certain other conditions are met. The elimination of these models will reduce non-cash interest expense for entities that have issued a convertible instrument that was within the scope of those models before the adoption of ASU 2020-06. Additionally, ASU 2020-06 requires operating lessee rights and obligations to be recognized as assets and liabilities on the balance sheet. In addition, interest on lease liabilities is to be recognized separately from the amortization of right-of-use assets in the Statement of Operations. Further, paymentsapplication of the principal portion of lease liabilities are to be classified as financing activities while payments of interest on lease liabilitiesif-converted method for calculating diluted earnings per share, and variable lease payments are to be classified as operating activities inprecludes the Statement of Cash Flows. When the standard is adopted, the Company will be required to recognize and measure leases at the beginninguse of the earliest period presented using a modified retrospective approach.treasury stock method. The provisions of ASU 2016-02 is effective2020-06 are applicable for fiscal years beginning after December 15, 2018,2021, with early application permitted. The Company is evaluating the anticipated impact of adopting the ASU on the consolidated financial statements.
In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows: Classification of Certain Cash Receipts and Cash Payments, which provides guidance on eight specific cash flow issues, including debt prepayments or debt extinguishment costs. Publicly-traded companies are required to adopt the update for reporting periodsadoption permitted no earlier than fiscal years beginning after December 15, 2017. This ASU will not have a material impact on the consolidated financial statements.
In October 2016, the FASB issued ASU 2016-16, Income Taxes: Intra-Entity Transfers of Assets Other Than Inventory, which requires that entities recognize the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. Publicly-traded companies are required to2020. An entity should adopt the update for reporting periodsprovisions at the beginning after December 15, 2017. This ASU will not have a material impact on the consolidated financial statements.
of its annual fiscal year. The Company is alsocurrently evaluating other pronouncements recently issued but not yet adopted. The adoptionthe impact of these pronouncements is not expected to have a material impactASU 2020-06 on ourits consolidated financial statements. Table of Contents Veeco Instruments Inc. and Subsidiaries Notes to the Consolidated Financial Statements - continued (unaudited) Note 2 -— Income (Loss) Per Common Share The Company considers unvested share-based awards that have non-forfeitable rights to dividends prior to vesting to be participating shares, which are treated as a separate class of security from the Company’s common shares for calculating per share data. Therefore, the Company applies the two-class method when calculating income (loss) per share. The two-class method is an earnings allocation formula that determines earnings per share for each class of common stock and participating security according to dividends declared and participation rights in undistributed earnings. However, since the holders of the participating shares are not obligated to fund losses, participating shares are excluded from the calculation of loss per share.
The dilutive effect of the Convertible Senior Notes on income (loss) per share is calculated using the treasury stock method since the Company has both the current intent and ability to settle the principal amount of the Convertible Senior Notes in cash. See Note 5, “Liabilities,” for additional information on the Convertible Senior Notes.
Basic income (loss) per share is calculated by dividing net income (loss) by the weighted average number of shares outstanding during the period under the two-class method.period. Diluted income per share is calculated by dividing net income by the weighted average number of shares used to calculate basic income (loss) per share plus the weighted average number of common share equivalents outstanding during the period. The dilutive effect of outstanding options to purchase common stock and non-participating share-based awards is considered in diluted income per share by application of the treasury stock method. The dilutive effect of performance share units is included in diluted income per common share in the periodsif the performance targets have been achieved.achieved, or would have been achieved if the reporting date was the end of the contingency period. The computations of basic and diluted income (loss) per share for the three and nine months ended September 30, 20172020 and 20162019 are as follows: | | Three months ended September 30, | | Nine months ended September 30, | | | | 2017 | | 2016 | | 2017 | | 2016 | | | | (in thousands, except per share amounts) | | Net income (loss) | | $ | (21,884 | ) | $ | (69,598 | ) | $ | (39,177 | ) | $ | (117,212 | ) | | | | | | | | | | | Net income (loss) per common share: | | | | | | | | | | Basic | | $ | (0.47 | ) | $ | (1.78 | ) | $ | (0.91 | ) | $ | (2.99 | ) | Diluted | | $ | (0.47 | ) | $ | (1.78 | ) | $ | (0.91 | ) | $ | (2.99 | ) | | | | | | | | | | | Basic weighted average shares outstanding | | 46,941 | | 39,131 | | 43,100 | | 39,193 | | Effect of potentially dilutive share-based awards | | — | | — | | — | | — | | Diluted weighted average shares outstanding | | 46,941 | | 39,131 | | 43,100 | | 39,193 | | | | | | | | | | | | Unvested participating shares excluded from basic weighted average shares outstanding since the securityholders are not obligated to fund losses | | 166 | | 469 | | 166 | | 469 | | | | | | | | | | | | Common share equivalents excluded from the diluted weighted average shares outstanding since Veeco incurred a net loss and their effect would be antidilutive | | 220 | | 140 | | 275 | | 45 | | | | | | | | | | | | Potentially dilutive non-participating shares excluded from the diluted calculation as their effect would be antidilutive | | 1,956 | | 2,030 | | 1,628 | | 2,042 | | | | | | | | | | | | Maximum potential shares to be issued for settlement of Convertible Senior Notes excluded from the diluted calculation as their effect would be antidilutive | | 8,618 | | — | | 8,618 | | — | |
| | | | | | | | | | | | | | | | Three months ended September 30, | | Nine months ended September 30, | | | | 2020 | | 2019 | | 2020 | | 2019 | | | | | (in thousands, except per share amounts) | | Net income (loss) | | $ | 580 | | $ | (11,767) | | $ | (8,290) | | $ | (45,862) | | Net income (loss) per common share: | | | | | | | | | | | | | | Basic | | $ | 0.01 | | $ | (0.25) | | $ | (0.17) | | $ | (0.97) | | Diluted | | $ | 0.01 | | $ | (0.25) | | $ | (0.17) | | $ | (0.97) | | | | | | | | | | | | | | | | Basic weighted average shares outstanding | | | 48,341 | | | 47,489 | | | 48,327 | | | 47,361 | | Effect of potentially dilutive share-based awards | | | 833 | | | — | | | — | | | — | | Diluted weighted average shares outstanding | | | 49,174 | | | 47,489 | | | 48,327 | | | 47,361 | | | | | | | | | | | | | | | | Common share equivalents excluded from the diluted weighted average shares outstanding since the Company incurred a net loss and their effect would be antidilutive | | | N/A | | | 403 | | | 650 | | | 302 | | Potentially dilutive shares excluded from the diluted calculation as their effect would be antidilutive | | | 984 | | | 1,874 | | | 1,029 | | | 1,893 | | Maximum potential shares to be issued for settlement of the 2023 and 2027 Notes excluded from the diluted calculation as their effect would be antidilutive | | | 15,354 | | | 8,618 | | | 15,354 | | | 8,618 | |
Note 3 — Business CombinationsAssets UltratechInvestments
On May 26, 2017, the Company completed its acquisition of Ultratech, Inc. (“Ultratech”). Ultratech designs, manufactures, and markets lithography, laser annealing, and inspection equipment for manufacturers of semiconductor devices, including front-end semiconductor manufacturing and advanced packaging. Ultratech also designs, manufactures, and markets atomic layer deposition (“ALD”) equipment for scientific and industrial applications. Ultratech’s customers are primarily located throughout the United States, EMEA, China, Japan, Taiwan, Singapore, and Korea. With the addition of Ultratech, the Company establishes itself as a leading equipment supplier in the advanced packaging market, forming a strong technology portfolio to address critical advanced packaging applications. The results of Ultratech’s operations have been included in the consolidated financial statements since the date of acquisition.
Ultratech shareholders received (i) $21.75 per share in cash and (ii) 0.2675 of a share of Veeco common stock for each Ultratech common share outstanding on the acquisition date. In connection with the Company’s continued finalization of purchase accounting, during the three months ended September 30, 2017, the Company decreased the fair value of acquired inventory and property, plant and equipment by $4.1 million and $1.2 million, respectively, resulting in a corresponding increase in goodwill. The Company plans to finalize the purchase accounting within the measurement period, which may include additional adjustments to the fair values of assets acquired and liabilities assumed. The preliminary acquisition date fair value of the consideration totaled $633.4 million, net of cash acquired, which consisted of the following:
| | Acquisition Date | | | | (May 26, 2017) | | | | (in thousands) | | Cash consideration, net of cash acquired | | $ | 404,489 | | Equity consideration (7.2 million shares issued) | | 228,644 | | Replacement equity awards attributable to pre-acquisition service | | 228 | | Acquisition date fair value | | $ | 633,361 | |
The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed at the acquisition date:
| | Acquisition Date | | | | (May 26, 2017) | | | | (in thousands) | | Short-term investments | | $ | 47,161 | | Accounts receivable | | 45,465 | | Inventory and deferred cost of sales | | 57,570 | | Prepaid expense and other current assets | | 7,217 | | Property, plant, and equipment | | 18,332 | | Intangible assets | | 346,940 | | Other assets | | 6,442 | | Total identifiable assets acquired | | 529,127 | | | | | | Accounts payable and accrued expenses | | 40,123 | | Customer deposits and deferred revenue | | 4,834 | | Deferred income taxes | | 32,478 | | Other liabilities | | 11,952 | | Total liabilities assumed | | 89,387 | | | | | | Net identifiable assets acquired | | 439,740 | | Goodwill | | 193,621 | | Net assets acquired | | $ | 633,361 | |
The gross contractual value of the acquired accounts receivable was approximately $46.0 million. The fair value of the accounts receivables is the amount expected to be collected by the Company. Goodwill generated from the acquisition is primarily attributable to expected synergies from future growth and strategic advantages provided through the expansion of product offerings as well as assembled workforce and is not expected to be deductible for income tax purposes.
The preliminary classes of intangible assets acquired and the estimated useful life of each class is presented in the table below:
| | Acquisition Date | | | | (May 26, 2017) | | | | Amount | | Useful life | | | | (in thousands) | | | | Technology | | $ | 158,390 | | 8 years | | Customer relationships | | 116,710 | | 12 years | | Backlog | | 3,080 | | 6 months | | In-process research and development | | 43,340 | | * | | Trademark and tradenames | | 25,420 | | 7 years | | Intangible assets acquired | | $ | 346,940 | | | |
*In-process research and development will be amortized (or impaired) upon completion (or abandonment) of the development project.
The Company determined the estimated fair value of the identifiable intangible assets based on various factors including: cost, discounted cash flow, income method, loss-of-revenue/income method, and relief-from-royalty method in determining the purchase price allocation.
In-process research and development (“IPR&D”) represents the estimated fair values of incomplete Ultratech research and development projects that had not reached the commercialization stage and meet the criteria for recognition as IPR&D as of the date of the acquisition. In the future, the fair value of each project at the acquisition date will be either amortized or impaired depending on whether the projects are completed or abandoned. The fair value of IPR&D was determined using an income approach and costs to complete the project and expected commercialization timelines are considered key assumptions. This valuation approach reflects the present value of the projected cash flows that are expected to be generated by the IPR&D less charges representing the contribution of other assets to those cash flows. The value of the IPR&D was determined to be $43.3 million, approximately half of which is related to Ultratech’s lithography technologies and one-third of which is related to Ultratech’s laser annealing technologies.
For the three and nine months ended September 30, 2017, acquisition related costs were approximately $0.8 million and $16.3 million, respectively, including non-cash charges of $4.2 million for the nine months ended September 30, 2017 related to accelerated share-based compensation for employee terminations.
The amounts of revenue and income (loss) from operations before income taxes of Ultratech included in the Company’s consolidated statement of operations for the three and nine months ended September 30, 2017 are as follows:
| | Three months ended September 30, 2017 | | Nine months ended September 30, 2017 | | | | (in thousands) | | Revenue | | $ | 21,236 | | $ | 45,286 | | Loss from operations before income taxes | | $ | (21,556 | ) | $ | (44,374 | ) |
Loss from operations before income taxes of Ultratech for the three month period ended September 30, 2017 of $21.6 million includes acquisition costs of $0.8 million, release of inventory fair value step-up related to purchase accounting of $1.9 million, amortization expense on intangible assets of $9.6 million, and restructuring charges of $2.1 million. Loss from operations before income taxes of Ultratech for the nine month period ended September 30, 2017 of $44.4 million includes acquisition costs of $16.3 million, release of inventory fair value step-up related to purchase accounting of $9.2 million, amortization expense on intangible assets of $13.1 million, and restructuring charges of $3.3 million.
The following table presents unaudited pro forma financial information as if the acquisition of Ultratech had occurred on January 1, 2016:
| | Three months ended September 30, | | Nine months ended September 30, | | | | 2017 | | 2016 | | 2017 | | 2016 | | | | (in thousands, except per share amounts) | | Revenue | | $ | 131,872 | | $ | 134,093 | | $ | 412,066 | | $ | 381,586 | | Loss from operations | | (14,957 | ) | (74,197 | ) | (45,309 | ) | (187,499 | ) | Diluted earnings per share | | $ | (0.40 | ) | $ | (1.67 | ) | $ | (1.01 | ) | $ | (4.34 | ) |
The pro-forma results were calculated by combining the unaudited results of the Company with the stand-alone unaudited results of Ultratech for the pre-acquisition period, and adjusting for the following:
(i) Additional amortization expense related to identified intangibles valued as part of the purchase price allocation that would have been incurred starting on January 1, 2016.
(ii) Additional depreciation expense for the property, plant, and equipment fair value adjustments that would have been incurred starting on January 1, 2016.
(iii) All acquisition related costs incurred by the Company as well as by Ultratech pre-acquisition have been removed from their respective periods and included in the three months ended March 31, 2016, as such expenses would have been incurred in the first quarter following the acquisition.
(iv) All amortization of inventory step-up has been removed from their respective periods and recorded in the first two quarters of 2016, as such costs would have been incurred as the corresponding inventory was sold.
(v) Additional interest expense related to the Convertible Senior Notes (see Note 5, “Liabilities”) as if they had been issued on January 1, 2016.
(vi) Income tax expense (benefit) was adjusted for the impact of the above adjustments for each period.
Note 4 - Assets
Investments
Short-term investments are generally classified as available-for-sale and reported at fair value, with unrealized gains and losses, net of tax, presented as a separate component of stockholders’ equity under the caption “Accumulated other comprehensive income” in the Consolidated Balance Sheets. These securities may include U.S. treasuries, government agency securities, corporate debt, and commercial paper, all with maturities of greater than three months when acquired.purchased. All realized gains and losses and unrealized losses resulting from declines in fair value that are other than temporary are included in “Other operating expense (income), net” in the Consolidated Statements of Operations. Fair value is the price that would be received for an asset or the amount paid to transfer a liability in an orderly transaction between market participants. Veeco classifies certain assets based on the following fair value hierarchy: Level 1: Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities; Table of Contents Veeco Instruments Inc. and Subsidiaries Notes to the Consolidated Financial Statements - continued (unaudited) Level 2: Quoted prices for identical assets and liabilities in markets that are not active, quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; and Level 3: Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Veeco has evaluated the estimated fair value of financial instruments using available market information and valuations as provided by third-party sources. The use of different market assumptions and/or estimation methodologies could have a significant effect on the estimated fair value amounts. The following table presents the portion of Veeco’s assets that were measured at fair value on a recurring basis at September 30, 20172020 and December 31, 2016:2019: | | Level 1 | | Level 2 | | Level 3 | | Total | | | | (in thousands) | | September 30, 2017 | | | | | | | | | | Cash equivalents | | | | | | | | | | Corporate debt | | $ | — | | $ | 1,500 | | $ | — | | $ | 1,500 | | Total | | $ | — | | $ | 1,500 | | $ | — | | $ | 1,500 | | Short-term investments | | | | | | | | | | U.S. treasuries | | $ | 58,806 | | $ | — | | $ | — | | $ | 58,806 | | Corporate debt | | — | | 10,911 | | — | | 10,911 | | Commercial paper | | — | | 16,136 | | — | | 16,136 | | Total | | $ | 58,806 | | $ | 27,047 | | $ | — | | $ | 85,853 | | | | | | | | | | | | December 31, 2016 | | | | | | | | | | Cash equivalents | | | | | | | | | | Corporate debt | | $ | — | | $ | 1,501 | | $ | — | | $ | 1,501 | | Total | | $ | — | | $ | 1,501 | | $ | — | | $ | 1,501 | | Short-term investments | | | | | | | | | | U.S. treasuries | | $ | 40,008 | | $ | — | | $ | — | | $ | 40,008 | | Government agency securities | | — | | 10,012 | | — | | 10,012 | | Corporate debt | | — | | 13,773 | | — | | 13,773 | | Commercial paper | | — | | 2,994 | | — | | 2,994 | | Total | | $ | 40,008 | | $ | 26,779 | | $ | — | | $ | 66,787 | |
| | | | | | | | | | | | | | | Level 1 | | Level 2 | | Level 3 | | Total | | | | (in thousands) | September 30, 2020 | | | | | | | | | | | | | Cash equivalents | | | | | | | | | | | | | Certificate of deposits and time deposits | | $ | 64,646 | | $ | — | | $ | — | | $ | 64,646 | U.S. treasuries | | | 9,999 | | | — | | | — | | | 9,999 | Government money market fund | | | 1,180 | | | — | | | — | | | 1,180 | Government agency securities | | | — | | | 1,050 | | | — | | | 1,050 | Total | | $ | 75,825 | | $ | 1,050 | | $ | — | | $ | 76,875 | Short-term investments | | | | | | | | | | | | | U.S. treasuries | | $ | 125,346 | | $ | — | | $ | — | | $ | 125,346 | Government agency securities | | | — | | | 6,000 | | | — | | | 6,000 | Corporate debt | | | — | | | 14,248 | | | — | | | 14,248 | Commercial paper | | | — | | | 15,991 | | | — | | | 15,991 | Total | | $ | 125,346 | | $ | 36,239 | | $ | — | | $ | 161,585 | | | | | | | | | | | | | | December 31, 2019 | | | | | | | | | | | | | Cash equivalents | | | | | | | | | | | | | Certificate of deposits and time deposits | | $ | 67,009 | | $ | — | | $ | — | | $ | 67,009 | Commercial paper | | | — | | | 10,484 | | | — | | | 10,484 | Corporate debt | | | — | | | 1,000 | | | — | | | 1,000 | Total | | $ | 67,009 | | $ | 11,484 | | $ | — | | $ | 78,493 | Short-term investments | | | | | | | | | | | | | U.S. treasuries | | $ | 105,130 | | $ | — | | $ | — | | $ | 105,130 | Government agency securities | | | — | | | 1,139 | | | — | | | 1,139 | Corporate debt | | | — | | | 6,002 | | | — | | | 6,002 | Commercial paper | | | — | | | 2,981 | | | — | | | 2,981 | Total | | $ | 105,130 | | $ | 10,122 | | $ | — | | $ | 115,252 |
There were no 0 transfersbetweenfair value measurement levels during the three and nine months ended September 30, 2017.2020. Table of Contents Veeco Instruments Inc. and Subsidiaries Notes to the Consolidated Financial Statements - continued (unaudited) At September 30, 20172020 and December 31, 2016,2019, the amortized cost and fair value of available-for-sale securities consist of: | | | | | | | | | | | | | | | | | | | | Gross | | Gross | | | | | | Amortized | | Unrealized | | Unrealized | | Estimated | | | | Cost | | Gains | | Losses | | Fair Value | | | | | Gross | | Gross | | | | | | | Amortized | | Unrealized | | Unrealized | | Estimated | | | | | Cost | | Gains | | Losses | | Fair Value | | | | | (in thousands) | | | September 30, 2017 | | | | | | | | | | | U.S. treasuries | | $ | 58,816 | | $ | 3 | | $ | (13 | ) | $ | 58,806 | | | Corporate debt | | 10,912 | | 1 | | (2 | ) | 10,911 | | | Commercial paper | | 16,135 | | 1 | | — | | 16,136 | | | Total | | $ | 85,863 | | $ | 5 | | $ | (15 | ) | $ | 85,853 | | | | | | | | | | | | | | December 31, 2016 | | | | | | | | | | | | | | (in thousands) | September 30, 2020 | | | | | | | | | | | | | | U.S. treasuries | | $ | 40,013 | | $ | — | | $ | (5 | ) | $ | 40,008 | | | $ | 125,333 | | $ | 17 | | $ | (4) | | $ | 125,346 | Government agency securities | | 10,020 | | — | | (8 | ) | 10,012 | | | | 5,995 | | | 5 | | | — | | | 6,000 | Corporate debt | | 13,780 | | — | | (7 | ) | 13,773 | | | | 14,254 | | | 1 | | | (7) | | | 14,248 | Commercial paper | | 2,994 | | — | | — | | 2,994 | | | | 15,986 | | | 7 | | | (2) | | | 15,991 | Total | | $ | 66,807 | | $ | — | | $ | (20 | ) | $ | 66,787 | | | $ | 161,568 | | $ | 30 | | $ | (13) | | $ | 161,585 | | | | | | | | | | | | | | | December 31, 2019 | | | | | | | | | | | | | | U.S. treasuries | | | $ | 105,096 | | $ | 38 | | $ | (4) | | $ | 105,130 | Government agency securities | | | | 1,139 | | | — | | | — | | | 1,139 | Corporate debt | | | | 6,003 | | | — | | | (1) | | | 6,002 | Commercial paper | | | | 2,981 | | | — | | | — | | | 2,981 | Total | | | $ | 115,219 | | $ | 38 | | $ | (5) | | $ | 115,252 |
Available-for-sale securities in a loss position at September 30, 20172020 and December 31, 20162019 consist of: | | September 30, 2017 | | December 31, 2016 | | | | | | Gross | | | | Gross | | | | Estimated | | Unrealized | | Estimated | | Unrealized | | | | Fair Value | | Losses | | Fair Value | | Losses | | | | (in thousands) | | U.S. treasuries | | $ | 41,864 | | $ | (13 | ) | $ | 20,002 | | $ | (5 | ) | Government agency securities | | — | | — | | 10,012 | | (8 | ) | Corporate debt | | 7,909 | | (2 | ) | 13,774 | | (7 | ) | Total | | $ | 49,773 | | $ | (15 | ) | $ | 43,788 | | $ | (20 | ) |
| | | | | | | | | | | | | | | September 30, 2020 | | December 31, 2019 | | | | | | Gross | | | | Gross | | | Estimated | | Unrealized | | Estimated | | Unrealized | | | Fair Value | | Losses | | Fair Value | | Losses | | | | | (in thousands) | U.S. treasuries | | $ | 40,111 | | $ | (4) | | $ | 22,943 | | $ | (4) | Corporate debt | | | 10,195 | | | (7) | | | 6,002 | | | (1) | Commercial paper | | | 5,995 | | | (2) | | | — | | | — | Total | | $ | 56,301 | | $ | (13) | | $ | 28,945 | | $ | (5) |
At September 30, 20172020 and December 31, 2016,2019, there were no0 short-term investments that had been in a continuous loss position for more than 12 months. The maturities of securities classified as available-for-sale securities at September 30, 20172020 were all contractually maturedue in one year or less.less, and an allowance for credit loss is considered unnecessary. Actual maturities may differ from contractual maturities. Veeco may sell these securities prior to maturity based on the needs of the business. In addition,maturities because borrowers may have the right to call or prepay obligations prior to scheduled maturities. with or without call or prepayment penalties. There were minimal realized gains or losses for the three and nine months ended September 30, 20172020 and no0 realized gains or lossesfor the three and nine months ended September 30, 2016. The cost of securities liquidated is based on specific identification.2019. Accounts receivableReceivable Accounts receivable is presented net of an allowance for doubtful accounts of $0.3$0.7 million and $0.6 million at September 30, 20172020 and December 31, 2016.2019, respectively. The Company considered its current expectations of future economic conditions, including the impact of COVID-19, when estimating its allowance for doubtful accounts. Table of Contents Veeco Instruments Inc. and Subsidiaries Notes to the Consolidated Financial Statements - continued (unaudited) Inventories Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. Inventories at September 30, 20172020 and December 31, 20162019 consist of the following:following:
| | | | | | | | | | | September 30, | | December 31, | | | | 2020 | | 2019 | | | September 30, | | December 31, | | | | | 2017 | | 2016 | | | | | (in thousands) | | | | | | (in thousands) | Materials | | $ | 59,767 | | $ | 46,457 | | | $ | 81,842 | | $ | 82,155 | Work-in-process | | 37,884 | | 25,250 | | | | 56,137 | | | 42,575 | Finished goods | | 16,030 | | 5,356 | | | | 5,490 | | | 8,337 | Total | | $ | 113,681 | | $ | 77,063 | | | $ | 143,469 | | $ | 133,067 |
Prepaid expensesExpenses and other current assetsOther Current Assets Prepaid expenses and other current assets primarily consist of supplier deposits, prepaid value-added tax, lease deposits, prepaid insurance, prepaid licenses, and prepaid licenses.other receivables. Veeco had deposits with its suppliers of $6.7$5.0 million and $7.8$5.9 million at September 30, 20172020 and December 31, 2016,2019, respectively. Additionally, Assets Held for Sale In the fourth quarter of 2019, the Company determined that one of its non-core product lines (the “disposal group”) met the held for sale criteria, and as such, the related assets were presented as “Assets held for sale” on the Consolidated Balance Sheets as of December 31, 2019. During the second quarter of 2020, the Company completed the sale of this product line for approximately $11.4 million, with approximately 85% of the transaction price received upon closing, and 15% held in escrow for a period of 18 months and included within prepaid expenses“Other Assets” in the Consolidated Balance Sheets. Long-lived assets and other currentdefinite-lived intangible assets were not depreciated or amortized while classified as held for sale. The sale of this disposal group does not represent a strategic shift that will have a material effect on the Company’s operations and financial results, nor is it considered a component of the Company, and as such it did not meet the criteria to be reported as discontinued operations. For the year ended December 31, 2019, the Company recorded a non-cash impairment charge on these assets held for sale of $4.0 million in order to measure the disposal group at September 30, 2017 wasthe lower of its carrying value or fair value less costs to sell, which resulted in a non-trade receivablecorresponding held for sale valuation allowance on its assets held for sale in the Consolidated Balance Sheet. During the second quarter of approximately $12.8 million.2020, the Company recorded additional impairment charges of $0.3 million related to the finalization of the sale of this disposal group. The major classes of assets and liabilities that were sold are as follows: | | | | | | | | Net assets sold: | | (in thousands) | Inventories | | $ | 6,311 | Property, plant, and equipment, net | | | 372 | Intangible assets, net | | | 6,546 | Goodwill | | | 2,359 | Deferred revenue | | | (59) | Total net assets sold | | $ | 15,529 | Net proceeds after costs to sell | | | (11,228) | Total loss on sale of disposal group | | $ | 4,301 |
Table of Contents Veeco Instruments Inc. and Subsidiaries Notes to the Consolidated Financial Statements - continued (unaudited) Property, plant,Plant, and equipmentEquipment Property, plant, and equipment at September 30, 20172020 and December 31, 20162019 consist of the following: | | September 30, | | December 31, | | | | 2017 | | 2016 | | | | (in thousands) | | Land | | $ | 5,669 | | $ | 5,669 | | Building and improvements | | 50,367 | | 50,814 | | Machinery and equipment(1) | | 126,631 | | 99,370 | | Leasehold improvements | | 10,471 | | 3,652 | | Gross property, plant and equipment | | 193,138 | | 159,505 | | Less: accumulated depreciation and amortization | | 108,735 | | 98,859 | | Net property, plant, and equipment | | $ | 84,403 | | $ | 60,646 | |
| | | | | | | | | September 30, | | December 31, | | | 2020 | | 2019 | | | | (in thousands) | Land | | $ | 5,061 | | $ | 5,061 | Building and improvements | | | 62,796 | | | 61,884 | Machinery and equipment (1) | | | 137,587 | | | 137,692 | Leasehold improvements | | | 6,795 | | | 6,703 | Gross property, plant, and equipment | | | 212,239 | | | 211,340 | Less: accumulated depreciation and amortization | | | 146,428 | | | 135,629 | Net property, plant, and equipment | | $ | 65,811 | | $ | 75,711 |
(1) | Machinery and equipment also includes software, furniture and fixtures |
(1) Machinery and equipment also includes software, furniture and fixtures
For the three and nine months ended September 30, 2017,2020, depreciation expense was $3.8 million and $11.5 million, respectively, and $4.2 million and $10.6 million, respectively, and $3.5 million and $10.2$13.1 million for the comparable 20162019 periods. Goodwill Goodwill represents the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. The following table presentsCompany continues to assess potential triggering events related to the changes invalue of its goodwill, balances forincluding the COVID-19 pandemic, and concluded that there were no indicators of impairment during the nine months ended September 30, 2017:2020. | | Gross carrying | | Accumulated | | | | | | amount | | impairment | | Net amount | | | | (in thousands) | | Balance at December 31, 2016 | | $ | 238,108 | | $ | 123,200 | | $ | 114,908 | | Acquisition | | 193,621 | | — | | 193,621 | | Balance at September 30, 2017 | | $ | 431,729 | | $ | 123,200 | | $ | 308,529 | |
Intangible assetsAssets Intangible assets consist of purchased technology, customer-related intangible assets, in-process researchcustomer relationships, patents, trademarks and development, trademarks (both long-livedtradenames, and indefinite-lived), patents, backlog, and licenses and are initially recorded at fair value. Long-lived intangiblesintangible assets are amortized over their estimated useful lives in a method reflecting the pattern in which the economic benefits are consumed or amortized on a straight-line basis if such pattern cannot be reliably determined. The Company continues to assess potential triggering events related to the value of its intangible assets, including the COVID-19 pandemic, and concluded that there were no indicators of impairment during the nine months ended September 30, 2020. The components of purchased intangible assets were as follows: | | | | September 30, 2017 | | December 31, 2016 | | | | Weighted | | | | Accumulated | | | | | | Accumulated | | | | | | Average Remaining | | Gross | | Amortization | | | | Gross | | Amortization | | | | | | Amortization | | Carrying | | and | | Net | | Carrying | | and | | Net | | | | Period | | Amount | | Impairment | | Amount | | Amount | | Impairment | | Amount | | | | (in years) | | (in thousands) | | Technology | | 7.5 | | $ | 307,588 | | $ | 125,154 | | $ | 182,434 | | $ | 149,198 | | $ | 113,904 | | $ | 35,294 | | Customer relationships | | 11.6 | | 164,595 | | 35,653 | | 128,942 | | 47,885 | | 28,659 | | 19,226 | | In-process R&D | | — | | 43,340 | | — | | 43,340 | | — | | — | | — | | Trademarks and tradenames | | 6.6 | | 28,010 | | 3,272 | | 24,738 | | 2,590 | | 1,948 | | 642 | | Indefinite-lived trademark | | — | | 2,900 | | — | | 2,900 | | 2,900 | | — | | 2,900 | | Other | | 0.5 | | 3,686 | | 2,444 | | 1,242 | | 2,026 | | 1,710 | | 316 | | Total | | 9.0 | | $ | 550,119 | | $ | 166,523 | | $ | 383,596 | | $ | 204,599 | | $ | 146,221 | | $ | 58,378 | |
| | | | | | | | | | | | | | | | | | | | | September 30, 2020 | | December 31, 2019 | | | | | | Accumulated | | | | | | | | Accumulated | | | | | | Gross | | Amortization | | | | Gross | | Amortization | | | | | Carrying | | and | | Net | | Carrying | | and | | Net | | | Amount | | Impairment | | Amount | | Amount | | Impairment | | Amount | | | | (in thousands) | Technology | | $ | 327,908 | | $ | 299,710 | | $ | 28,198 | | $ | 327,908 | | $ | 291,766 | | $ | 36,142 | Customer relationships | | | 146,465 | | | 129,290 | | | 17,175 | | | 146,465 | | | 126,764 | | | 19,701 | Trademarks and tradenames | | | 30,910 | | | 26,274 | | | 4,636 | | | 30,910 | | | 25,256 | | | 5,654 | Other | | | 3,686 | | | 3,679 | | | 7 | | | 3,686 | | | 3,665 | | | 21 | Total | | $ | 508,969 | | $ | 458,953 | | $ | 50,016 | | $ | 508,969 | | $ | 447,451 | | $ | 61,518 |
Other intangible assets primarily consist of patents, backlog,licenses, and licenses.backlog. Table of Contents Veeco Instruments Inc. and Subsidiaries Other assets
Veeco has an ownership interest of less than 20% in a non-marketable investment, Kateeva, Inc. (“Kateeva”). Veeco does not exert significant influence over Kateeva and therefore the investment is carried at cost. There was no changeNotes to the $21.0 million carrying value of the investment during the nine months ended September 30, 2017. The investment is included in “Other assets” on the Consolidated Balance Sheets. The investment is subject to a periodic impairment review; as there are no open-market valuations, the impairment analysis requires judgment. The analysis includes assessments of Kateeva’s financial condition, the business outlook for its products and technology, its projected results and cash flow, business valuation indications from recent rounds of financing, the likelihood of obtaining subsequent rounds of financing, and the impact of equity preferences held by Veeco relative to other investors. Fair value of the investment is not estimated unless there are identified events or changes in circumstances that could have a significant adverse effect on the fair value of the investment. No such events or circumstances are present.
Also included within Other assets at September 30, 2017 are deferred compensation plan assets of approximately $3.3 million representing the cash surrender value of life insurance policies held by the Company related to an executive non-qualified deferred compensation plan that was assumed from Ultratech that allows qualifying executives to defer cash compensation. The related plan liability of approximately $4.5 million is included in “Other liabilities” on the Consolidated Balance Sheet.
Financial Statements - continued Note 5 - Liabilities(unaudited)
Note 4 — Liabilities Accrued expensesExpenses and other current liabilitiesOther Current Liabilities The components of accrued expenses and other current liabilities at September 30, 20172020 and December 31, 20162019 consist of: | | | | | | | | | | | September 30, | | December 31, | | | | 2020 | | 2019 | | | September 30, | | December 31, | | | | | 2017 | | 2016 | | | | | (in thousands) | | | | | | (in thousands) | Payroll and related benefits | | $ | 27,816 | | $ | 18,780 | | | $ | 21,755 | | $ | 15,174 | Merger consideration payable | | 17,844 | | — | | | Warranty | | 6,555 | | 4,217 | | | | 5,141 | | | 7,067 | Operating lease liabilities | | | | 4,177 | | | 4,196 | Interest | | | | 3,189 | | | 4,321 | Professional fees | | 3,349 | | 1,827 | | | | 963 | | | 2,443 | Installation | | 1,418 | | 1,382 | | | Sales, use, and other taxes | | 1,961 | | 1,282 | | | | 2,466 | | | 811 | Restructuring liability | | 1,893 | | 1,796 | | | | 671 | | | 2,841 | Interest | | 2,307 | | — | | | Other | | 2,585 | | 3,917 | | | | 2,305 | | | 4,390 | Total | | $ | 65,728 | | $ | 33,201 | | | $ | 40,667 | | $ | 41,243 |
Warranty Warranties are typically valid for one year from the date of system final acceptance, and Veeco estimates the costs that may be incurred under the warranty. Estimated warranty costs are determined by analyzing specific product and historical configuration statistics and regional warranty support costs and are affected by product failure rates, material usage, and labor costs incurred in correcting product failures during the warranty period. Unforeseen component failures or exceptional component performance can also result in changes to warranty costs. Changes in product warranty reserves for the nine months ended September 30, 20172020 include: | | (in thousands) | | Balance - December 31, 2016 | | $ | 4,217 | | Warranties issued | | 4,314 | | Addition from Ultratech acquisition | | 1,889 | | Consumption of reserves | | (4,741 | ) | Changes in estimate | | 876 | | Balance - September 30, 2017 | | $ | 6,555 | |
| | | | | | | (in thousands) | Balance - December 31, 2019 | | $ | 7,067 | Warranties issued | | | 2,747 | Consumption of reserves | | | (4,771) | Changes in estimate | | | 98 | Balance - September 30, 2020 | | $ | 5,141 |
Restructuring accrualsAccruals During 2016,The Company recorded restructuring charges during the Company undertook restructuring activitiesyear ended December 31, 2019 as parta result of its initiativeefforts to further streamline operations, enhance efficiencies, and reduce costs, as well as reducing future investments in certain technologycosts. In the second half of 2019, the Company executed an initiative to reorganize various functions along product lines and created a central research and development which togetherorganization to better allocate its resources to the Company’s highest priority projects. In addition, the Company delayered the organization. Collectively, these actions impacted approximately 7560 employees. In addition, during 2017, the Company began the acquisition integration process to enhance efficiencies, resulting in additional employee terminations and other facility closing costs. Over the next few quarters, the Company expects to incur additional restructuring costs of $1 million to $5 million as it finalizes all of these activities.
| | Personnel | | | | | | | | Severance and | | Facility | | | | | | Related Costs | | Closing Costs | | Total | | | | (in thousands) | | Balance - December 31, 2016 | | $ | 1,796 | | $ | — | | $ | 1,796 | | Provision | | 3,628 | | 4,269 | | 7,897 | | Payments | | (3,531 | ) | (4,269 | ) | (7,800 | ) | Balance - September 30, 2017 | | $ | 1,893 | | $ | — | | $ | 1,893 | |
Included within restructuring expense in the Consolidated Statements of Operations forDuring the nine months ended September 30, 2017 is approximately $1.7 million of non-cash charges2020, additional accruals were recognized and payments were made related to accelerated share-based compensationthese restructuring initiatives.
The following table shows the amounts incurred and paid for employee terminations.restructuring activities during the nine months ended September 30, 2020, and the remaining accrued balance of restructuring costs at September 30, 2020, which is included Table of Contents Veeco Instruments Inc. and Subsidiaries Notes to the Consolidated Financial Statements - continued (unaudited) in “Accrued expenses and other current liabilities” in the Consolidated Balance Sheets, and principally consists of personnel severance and related costs: | | | | | | | | | | | | | | | | | (in thousands) | Balance - December 31, 2019 | | $ | 2,841 | Provision | | | 1,097 | Payments | | | (3,267) | Balance - September 30, 2020 | | $ | 671 |
Customer depositsDeposits and Deferred Revenue Customer deposits totaled $27.6$54.3 million and $22.2$26.6 million at September 30, 20172020 and December 31, 2016,2019, respectively. Deferred revenue represents amounts billed, other than deposits, in excess of the revenue that can be recognized on a particular contract at the balance sheet date. Changes in deferred revenue were as follows: | | | | | | (in thousands) | Balance - December 31, 2019 | | $ | 28,249 | Deferral of revenue | | | 7,391 | Recognition of previously deferred revenue | | | (18,370) | Balance - September 30, 2020 | | $ | 17,270 |
Mortgage Payable
At December 31, 2016,As of September 30, 2020, the Company had a mortgage note payable associatedhas approximately $27.3 million of remaining performance obligations on contracts with its property in St. Paul, Minnesota,an original estimated duration of one year or more, of which during the third quarter of 2017 was fully extinguished in connectionapproximately 72% is expected to be recognized within one year, with the sale of the building. The carrying value of the property exceeded the carrying value of the mortgage note of $1.2 million at December 31, 2016. The annual interest rate on the note was 7.91%remaining amounts expected to be recognized between one to three years. The Company determined the mortgage was a Level 3 liability in the fair-value hierarchy and, using a discounted cash flow model, estimated its fair value as $1.2 million at December 31, 2016.has elected to exclude disclosures regarding remaining performance obligations that have an original expected duration of one year or less.
Convertible Senior Notes 2023 Notes On January 10, 2017, the Company issued $345.0 million of 2.70% convertible senior unsecured notes due (the “Convertible Senior“2023 Notes”). The Company received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company, of approximately $335.8 million. The Convertible Senior2023 Notes bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The Convertible Senior2023 Notes mature on January 15, 2023, unless earlier purchased by the Company, redeemed, or converted. On May 18, 2020, in connection with the completion of a private offering of $125 million aggregate principal amount of 3.75% convertible senior notes described below, the Company repurchased and retired approximately $88.3 million in aggregate principal amount of its outstanding 2023 Notes, with a carrying amount of $78.1 million, for approximately $81.2 million of cash. The Company accounted for the partial settlement of the 2023 Notes as an extinguishment, and as such, recorded a loss on extinguishment of approximately $3.0 million for the nine months ended September 30, 2020. 2027 Notes On May 18, 2020, the Company completed a private offering of $125.0 million of 3.75% convertible senior notes (the “2027 Notes”). The Company received net proceeds of approximately $121.9 million, after deducting underwriting discounts and fees and expenses payable by the Company. Additionally, the Company used approximately $10.3 million of cash to purchase the capped calls, discussed below. The 2027 Notes bear interest at a rate of 3.75% per year, payable Table of Contents Veeco Instruments Inc. and Subsidiaries Notes to the Consolidated Financial Statements - continued (unaudited) semiannually in arrears on June 1 and December 1 of each year, commencing on December 1, 2020. The 2027 Notes mature on June 1, 2027 (the “Maturity Date”), unless earlier purchased by the Company, redeemed, or converted. The Convertible Senior2027 Notes are unsecured obligations of Veecothe Company and rank senior in right of payment to any of Veeco’sthe Company’s subordinated indebtedness; equal in right of payment to all of Veeco’sthe Company’s unsecured indebtedness that is not subordinated; subordinated (including the Company’s unsecured trade payables and the 2023 Notes); effectively subordinated in right of payment to any of Veeco’sthe Company’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally subordinated to all indebtedness and other liabilities (including trade payables) of Veeco’sthe Company’s subsidiaries. The Convertible Senior2027 Notes are convertible into cash, sharesat the option of the Company’s common stock, or a combination thereof, at the Company’s election,holders upon the satisfaction of specified conditions and during certain periods as described below. The initial conversion rate is 24.980071.5372 shares of the Company’s common stock per $1,000 principal amount of Convertible Senior2027 Notes, representing an initial effective conversion price of $40.03$13.98 per share of common stock. The conversion rate may be subject to adjustment upon the occurrence of certain specified events as provided in the indenture governing the Convertible Senior2027 Notes, dated January 18, 2017 between the Company and U.S. Bank National Association, as trustee (the “Indenture”), but will not be adjusted for accrued but unpaid interest. Holders may convert all or any portion of their notes, in multiples of one thousand dollar$1,000 principal amount, at their option at any time prior to the close of business on the business day immediately preceding October 15, 20221, 2026 only under the following circumstances: | (i) | During any calendar quarter commencing after the calendar quarter ending September 30, 2020 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; |
| (ii) | During the 5 business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per 1 thousand dollar principal amount of 2027 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate in effect on each such trading day; |
| (iii) | If the Company calls any or all of the 2027 Notes for redemption at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or |
| (iv) | Upon the occurrence of specified corporate events. |
(i) During any calendar quarter (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;
(ii) During the five consecutive business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per one thousand dollar principal amount of Convertible Senior Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of Veeco’s common stock and the conversion rate on each such trading day;
(iii) If the Company calls any or all of the Convertible Senior Notes for redemption at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or
(iv) Upon the occurrence of specified corporate events.
On or after October 15, 2022,1, 2026, until the close of business on the business day immediately preceding the Maturity Date, holders may convert their notes at any time, regardless of the foregoing circumstances. Upon conversion by the holders, the Company may elect to settle such conversion in shares of its common stock, cash, or a combination thereof. As a result of its cash conversion option, the Company segregated the liability component of the instrument from the equity component. The liability component was measured by estimating the fair value of a non-convertible debt instrument that is similar in its terms to the Convertible Senior2027 Notes. The calculation of the fair value of the debt component required the use of Level 3 inputs, including utilization of convertible investors’ credit assumptions and industry high yield bond indices. Fair value was estimated through discounting future interest and principal payments, an income approach, due under the Convertible Senior2027 Notes at a discount rate of 7.00%9.10%, an interest rate equal to the estimated borrowing rate for similar non-convertible debt. The excess of the aggregate face value of the Convertible Senior2027 Notes over the estimated fair value of the liability component of $72.5$34.2 million was recognized as a debt discount and recorded as an increase to additional paid-in capital and will be amortized over the expected life of the Convertible Senior2027 Notes using the effective interest rate method. Amortization of the debt discount is recognized as non-cash interest expense. Table of Contents Veeco Instruments Inc. and Subsidiaries Notes to the Consolidated Financial Statements - continued (unaudited) The transaction costs of $9.2$3.1 million incurred in connection with the issuance of the Convertible Senior2027 Notes were allocated to the liability and equity components based on their relative values. Transaction costs allocated to the liability component are being amortized using the effective interest rate method and recognized as non-cash interest expense over the expected term of the Convertible Senior2027 Notes. Transaction costs allocated to the equity component of $1.9$0.8 million reduced the value of the equity component recognized in stockholders’stockholders' equity. In connection with the offering of the 2027 Notes, on May 13, 2020, the Company entered into privately negotiated capped call transactions (the “Capped Call Transactions”), pursuant to capped call confirmations, covering the total principal amount of the 2027 Notes for an aggregate premium of $10.3 million. The Capped Call Transactions are expected generally to reduce the potential dilution to the Company’s common stock upon any conversion of the 2027 Notes and/or offset any cash payments the Company is required to make in excess of the aggregate principal amount of converted 2027 Notes, as the case may be, with such reduction and/or offset subject to a cap based on the capped price of the Capped Call Transactions. The Capped Call Transactions exercise price is equal to the initial conversion price of the 2027 Notes, and the capped price of the Capped Call Transactions is approximately $18.46 per share and is subject to certain adjustments under the terms of the capped call confirmations. The Capped Call Transactions are separate transactions entered into by the Company with the capped call counterparties, are not part of the terms of the 2027 Notes and will not change the holders’ rights under the 2027 Notes. Holders of the 2027 Notes will not have any rights with respect to the Capped Call Transactions. The cost of the Capped Call Transactions is not expected to be tax-deductible as the Company did not elect to integrate the Capped Call Transactions into the respective convertible notes for tax purposes. The cost of the Capped Call Transactions was recorded as a reduction of the Company’s additional paid-in capital in the accompanying consolidated financial statements. The carrying value of the Convertible Senior2023 Notes isand 2027 Notes are as follows: | | September 30, | | | | 2017 | | | | (in thousands) | | Principal amount | | $ | 345,000 | | Unamortized debt discount | | (65,570 | ) | Unamortized transaction costs | | (6,605 | ) | Net carrying value | | $ | 272,825 | |
| | | | | | | | | | | | | | | | | | | | | | September 30, 2020 | | | December 31, 2019 | | | | 2023 Notes | | | 2027 Notes | | | Total | | | 2023 Notes | | | 2027 Notes | | | Total | | | | | (in thousands) | Principal amount | | $ | 256,695 | | $ | 125,000 | | $ | 381,695 | | $ | 345,000 | | $ | — | | $ | 345,000 | Unamortized debt discount | | | (23,488) | | | (32,889) | | | (56,377) | | | (40,820) | | | — | | | (40,820) | Unamortized transaction costs | | | (2,366) | | | (2,134) | | | (4,500) | | | (4,112) | | | — | | | (4,112) | Net carrying value | | $ | 230,841 | | $ | 89,977 | | $ | 320,818 | | $ | 300,068 | | $ | — | | $ | 300,068 |
Total interest expense related to the Convertible Senior2023 Notes and 2027 Notes is as follows: | | Three months ended September 30, | | Nine months ended September 30, | | | | 2017 | | 2017 | | | | (in thousands) | | Cash Interest Expense | | | | | | Coupon interest expense | | $ | 2,329 | | $ | 6,573 | | Non-Cash Interest Expense | | | | | | Amortization of debt discount | | 2,502 | | 6,942 | | Amortization of transaction costs | | 252 | | 699 | | Total Interest Expense | | $ | 5,083 | | $ | 14,214 | |
| | | | | | | | | | | | | | | | Three months ended September 30, | | Nine months ended September 30, | | | | 2020 | | 2019 | | 2020 | | 2019 | | | | | (in thousands) | | Cash Interest Expense | | | | | | | | | | | | | | Coupon interest expense - 2023 Notes | | $ | 1,733 | | $ | 2,329 | | $ | 6,060 | | $ | 6,986 | | Coupon interest expense - 2027 Notes | | | 1,172 | | | — | | | 1,745 | | | — | | Non-cash Interest Expense | | | | | | | | | | | | | | Amortization of debt discount - 2023 Notes | | | 2,328 | | | 2,906 | | | 8,074 | | | 8,556 | | Amortization of debt discount - 2027 Notes | | | 884 | | | — | | | 1,310 | | | — | | Amortization of transaction costs - 2023 Notes | | | 235 | | | 293 | | | 813 | | | 862 | | Amortization of transaction costs - 2027 Notes | | | 57 | | | — | | | 85 | | | — | | Total Interest Expense | | $ | 6,409 | | $ | 5,528 | | $ | 18,087 | | $ | 16,404 | |
Table of Contents Veeco Instruments Inc. and Subsidiaries Notes to the Consolidated Financial Statements - continued (unaudited) The Company determined the Convertible Senior2023 Notes is a and 2027 Notes are Level 2 liability liabilities in the fair value hierarchy and had an estimated its fair value as $330.9 million at September 30, 2017.2020 of $235.9 million and $134.8 million, respectively. Other Liabilities As part of the acquisition of Ultratech, the Company assumed an executive non-qualified deferred compensation plan that allowed qualifying executives to defer cash compensation. The plan was frozen at the time of acquisition and 0 further contributions have been made. At September 30, 2020 and December 31, 2019, plan assets approximated $2.2 million and $2.7 million, respectively, representing the cash surrender value of life insurance policies and is included within “Other assets” in the Consolidated Balance Sheets, while plan liabilities approximated $2.3 million and $3.1 million, respectively, and is included within “Other liabilities” in the Consolidated Balance Sheets. Other liabilities at September 30, 20172020 and December 31, 2019 also included deferred compensation(i) medical and dental benefits for former executives of $4.5$1.9 million and $2.0 million, respectively; (ii) asset retirement obligations of $3.3 million, medical and dental benefits of $2.5$2.7 million and acquisition related accruals of $0.7 million. At December 31, 2016, other liabilities primarily consisted of a non-current$3.2 million, respectively; and (iii) income tax payablepayables of $4.9 million.$1.4 and $1.0 million, respectively. Additionally, as a result of the Coronavirus, Aid, Relief, and Economic Security Act, the Company has accrued for and defered the deposit and payment of its share of social security taxes, resulting in a liability of $2.6 million at September 30, 2020, which is included within “Other liabilities” in the Consolidated Balance Sheets. Note 6 -5 — Commitments and Contingencies MinimumLeases
The Company’s operating leases primarily include real estate leases for properties used for manufacturing, R&D activities, sales and service, and administration, as well as certain equipment leases. Some leases may include options to renew for a period of up to 5 years, while others may include options to terminate the lease. The weighted average remaining lease commitments Atterm of the Company’s operating leases as of September 30, 2017, Veeco’s total2020 was 2.6 years, and the weighted average discount rate used in determining the present value of future minimum lease payments under non-cancelablewas 6.0%.
Table of Contents Veeco Instruments Inc. and Subsidiaries Notes to the Consolidated Financial Statements - continued (unaudited) The following table provides the maturities of lease liabilities at September 30, 2020: | | | | | | Operating | | | Leases | | | (in thousands) | Payments due by period: | | | | 2020 | | $ | 1,274 | 2021 | | | 4,659 | 2022 | | | 4,394 | 2023 | | | 1,035 | 2024 | | | 551 | Thereafter | | | — | Total future minimum lease payments | | | 11,913 | Less: Imputed interest | | | (943) | Total | | $ | 10,970 | | | | | Reported as of September 30, 2020 | | | | Accrued expenses and other current liabilities | | $ | 4,177 | Operating lease long-term liabilities | | | 6,793 | Total | | $ | 10,970 |
Operating lease cost for both the three months ended September 30, 2020 and 2019 was $1.3 million. Operating lease cost for both the nine months ended September 30, 2020 and 2019 was $4.1 million. Variable lease cost for the three and nine months ended September 30, 2020 was $0.4 and $1.3 million, respectively, and $0.4 and $1.4 million for the comparable 2019 periods. Additionally, the Company has an immaterial amount of short-term leases. Operating cash outflows from operating leases (exclusive of renewal options) are payable as follows:for the nine months ended September 30, 2020 and 2019 were $4.8 million and $5.0 million, respectively. | | Operating Leases | | | | (in thousands) | | Payments due by period: | | | | 2017 | | $ | 1,678 | | 2018 | | 5,474 | | 2019 | | 5,002 | | 2020 | | 4,763 | | 2021 | | 1,807 | | Thereafter | | 4,505 | | Total | | $ | 23,229 | |
Purchase commitmentsCommitments Veeco has purchase commitments of $151.7$103.6 million at September 30, 2017,2020, substantially all of which become due within one year. Bank guaranteesGuarantees Veeco has bank guarantees and letters of credit issued by a financial institution on its behalf as needed. At September 30, 2017,2020, outstanding bank guarantees and standby letters of credit totaled $3.7$5.8 million, and unused bank guarantees and letters of credit of $67.9$26.3 million were available to be drawn upon. Legal proceedingsProceedings On September 21, 2017, Blueblade Capital Opportunities LLCJune 8, 2018, an Ultratech shareholder who received Veeco stock as part of the consideration for the Ultratech acquisition filed a purported class action complaint in the Superior Court of the State of California, County of Santa Clara, captioned Wolther v. Maheshwari et al., Case No. 18CV329690, on behalf of purported beneficial owners of 440,100himself and others who purchased or acquired shares of Veeco pursuant to the registration statement and prospectus which Veeco filed with the SEC in connection with the Ultratech common stock,acquisition (the “Wolther Action”). On August 2 and August 8, 2018, 2 purported class action complaints substantially similar to the Wolther Action were filed an action against Ultratechon behalf of different plaintiffs in Delaware Court of Chancery requesting an appraisalthe same court as the Wolther Action. These cases have been consolidated with the Wolther Action, and a consolidated complaint was filed on December 11, 2018. The consolidated complaint seeks to recover damages and fees under Sections 11, 12, and 15 of the valueSecurities Act of their Ultratech stock pursuant to 8 Del. C. §262. The Company believes that the merger price, which was the product of arms-length negotiations, was fair and reasonable, and intends to contest the appraisal claim. Discovery1933 for, among other things, alleged false/misleading statements in the matter has commenced.registration statement Table of Contents On April 12, 2017, the Company filed a patent infringement complaint in the U.S. District Court for the Eastern District of New York against SGL Carbon, LLC and SGL Carbon SE (collectively, “SGL”), alleging infringement of patents relating to wafer carrier technology used in MOCVD equipment. The complaint alleges that SGL infringes Veeco’s patents by making and selling certain wafer carriers to Veeco’s competitor, Advanced Micro-Fabrication Equipment, Inc. (“AMEC”). On November 2, 2017, the U.S. District Court granted the Company’s motion for a preliminary injunction prohibiting SGL from shipping wafer carriers using the Company’s patented technology without the Company’s express authorization. The Company continues to seek a post-trial permanent injunction and monetary damages against SGL.
On July 13, 2017, AMEC filed a patent infringement complaint against Veeco Instruments Shanghai Co., Ltd. (“Veeco Shanghai”) withInc. and Subsidiaries
Notes to the Fujian High Court in China, alleging that the Company’s MOCVD products infringed a Chinese utility model patentConsolidated Financial Statements - continued (unaudited) and prospectus relating to the synchronous movement engagement mechanismUltratech acquisition, relating primarily to the alleged failure to disclose delays in the advanced packaging business, increased MOCVD competition in China, and an intellectual property dispute. Veeco is defending this matter vigorously. On December 21, 2018, a chemical vapor deposition reactor and seeking injunctive relief and monetary damages againstpurported Veeco Shanghai. The Company believes this complaint is without merit and intends to vigorously defend against these allegations. The Company hasstockholder filed a petition for invalidation of this patent withderivative action in the Chinese Patent Reexamination Board (“PRB”). The Fujian HighSuperior Court has suspended the infringement case against Veeco pending the outcome of the invalidation proceeding atState of California, County of Santa Clara, captioned Vladimir Gusinsky Revocable Trust v. Peeler, et al., Case No. 18CV339925, on behalf of nominal defendant Veeco. The complaint seeks to assert claims for breach of fiduciary duty, waste of corporate assets, and unjust enrichment against current and former Veeco directors premised on purported misstatements and omissions in the PRB.registration statement relating to the Ultratech acquisition. Veeco is defending this matter vigorously. The Company is involved in various other legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows. Note 6 — Derivative Financial Instruments The Company is exposed to financial market risks arising from changes in currency exchange rates. Changes in currency exchange rates could affect the Company’s foreign currency denominated monetary assets and liabilities and forecasted cash flows. The Company enters into monthly forward derivative contracts from time to time with the intent of mitigating a portion of this risk. The Company only uses derivative financial instruments in the context of hedging and not for speculative purposes and had not designated its foreign exchange derivatives as hedges. Accordingly, changes in fair value from these contracts are recorded as “Other operating expense (income), net” in the Company’s Consolidated Statements of Operations. The Company executes derivative transactions with highly rated financial institutions to mitigate counterparty risk. The Company did not have any outstanding derivative contracts at September 30, 2020 or December 31, 2019. Additionally, the Company did not have any gains or losses from currency exchange derivatives during the nine months ended September 30, 2020 and 2019. Table of Contents Veeco Instruments Inc. and Subsidiaries Notes to the Consolidated Financial Statements - continued (unaudited) Note 7 -— Equity Statement of Stockholders’ Equity The following tables present the changes in Stockholders’ Equity: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Accumulated | | | | | | | | | | | Additional | | | | | Other | | | | | | Common Stock | | Paid-in | | Accumulated | | Comprehensive | | | | | | Shares | | Amount | | Capital | | Deficit | | Income | | Total | | | | (in thousands) | Balance at December 31, 2019 | | 48,994 | | $ | 490 | | $ | 1,071,058 | | $ | (698,930) | | $ | 1,894 | | $ | 374,512 | Net income (loss) | | — | | | — | | | — | | | (567) | | | — | | | (567) | Other comprehensive income (loss), net of tax | | — | | | — | | | — | | | — | | | 153 | | | 153 | Share-based compensation expense | | — | | | — | | | 3,646 | | | — | | | — | | | 3,646 | Net issuance under employee stock plans | | 434 | | | 4 | | | (684) | | | — | | | — | | | (680) | Balance at March 31, 2020 | | 49,428 | | $ | 494 | | $ | 1,074,020 | | $ | (699,497) | | $ | 2,047 | | $ | 377,064 | Net income (loss) | | — | | | — | | | — | | | (8,302) | | | — | | | (8,302) | Other comprehensive income (loss), net of tax | | — | | | — | | | — | | | — | | | (130) | | | (130) | Share-based compensation expense | | — | | | — | | | 2,974 | | | — | | | — | | | 2,974 | Net issuance under employee stock plans | | 191 | | | 2 | | | 753 | | | — | | | — | | | 755 | Extinguishment of equity component of repurchased 2023 Notes | | — | | | — | | | (80) | | | — | | | — | | | (80) | Equity component of 2027 Notes | | — | | | — | | | 33,363 | | | — | | | — | | | 33,363 | Purchase of capped calls | | — | | | — | | | (10,313) | | | — | | | — | | | (10,313) | Balance at June 30, 2020 | | 49,619 | | $ | 496 | | $ | 1,100,717 | | $ | (707,799) | | $ | 1,917 | | $ | 395,331 | Net income (loss) | | — | | | — | | | — | | | 580 | | | — | | | 580 | Other comprehensive income, net of tax | | — | | | — | | | — | | | — | | | (60) | | | (60) | Share-based compensation expense | | — | | | — | | | 2,942 | | | — | | | — | | | 2,942 | Net issuance under employee stock plans | | (7) | | | — | | | (700) | | | — | | | — | | | (700) | Balance at September 30, 2020 | | 49,612 | | $ | 496 | | $ | 1,102,959 | | $ | (707,219) | | $ | 1,857 | | $ | 398,093 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Accumulated | | | | | | | | | | | | | | | | | Additional | | | | | Other | | | | | | Common Stock | | Treasury Stock | | Paid-in | | Accumulated | | Comprehensive | | | | | | Shares | | Amount | | Shares | | Amount | | Capital | | Deficit | | Income | | Total | | | | (in thousands) | Balance at December 31, 2018 | | 48,547 | | $ | 485 | | | 523 | | $ | (5,872) | | $ | 1,061,325 | | $ | (619,983) | | $ | 1,820 | | $ | 437,775 | Net income (loss) | | — | | | — | | | — | | | — | | | — | | | (18,530) | | | — | | | (18,530) | Other comprehensive income (loss), net of tax | | — | | | — | | | — | | | — | | | — | | | — | | | 38 | | | 38 | Share-based compensation expense | | — | | | — | | | — | | | — | | | 3,157 | | | — | | | — | | | 3,157 | Net issuance under employee stock plans | | 128 | | | 2 | | | (523) | | | 5,872 | | | (6,303) | | | (213) | | | — | | | (642) | Balance at March 31, 2019 | | 48,675 | | $ | 487 | | | — | | $ | — | | $ | 1,058,179 | | $ | (638,726) | | $ | 1,858 | | $ | 421,798 | Net income (loss) | | — | | | — | | | — | | | — | | | — | | | (15,565) | | | — | | | (15,565) | Other comprehensive income (loss), net of tax | | — | | | — | | | — | | | — | | | — | | | — | | | 20 | | | 20 | Share-based compensation expense | | — | | | — | | | — | | | — | | | 4,588 | | | — | | | — | | | 4,588 | Net issuance under employee stock plans | | 296 | | | 3 | | | — | | | — | | | 182 | | | — | | | — | | | 185 | Balance at June 30, 2019 | | 48,971 | | $ | 490 | | | — | | $ | — | | $ | 1,062,949 | | $ | (654,291) | | $ | 1,878 | | $ | 411,026 | Net income (loss) | | — | | | — | | | — | | | — | | | — | | | (11,767) | | | — | | | (11,767) | Other comprehensive income, net of tax | | — | | | — | | | — | | | — | | | — | | | — | | | (42) | | | (42) | Share-based compensation expense | | — | | | — | | | — | | | — | | | 3,783 | | | — | | | — | | | 3,783 | Net issuance under employee stock plans | | (68) | | | (1) | | | — | | | — | | | (529) | | | — | | | — | | | (530) | Balance at September 30, 2019 | | 48,903 | | $ | 489 | | | — | | $ | — | | $ | 1,066,203 | | $ | (666,058) | | $ | 1,836 | | $ | 402,470 |
Table of Contents Veeco Instruments Inc. and Subsidiaries Notes to the Consolidated Financial Statements - continued (unaudited) Accumulated Other Comprehensive Income (“AOCI”) The following table presents the changes in the balances of each component of AOCI, net of tax: | | | | Unrealized | | | | | | Foreign Currency | | Gains (Losses) on Available for Sale | | | | | | Translation | | Securities | | Total | | | | (in thousands) | | Balance - December 31, 2016 | | $ | 1,797 | | $ | (20 | ) | $ | 1,777 | | Other comprehensive income (loss) | | 25 | | 10 | | 35 | | Balance - September 30, 2017 | | $ | 1,822 | | $ | (10 | ) | $ | 1,812 | |
| | | | | | | | | | | | | | Unrealized | | | | | | | | Gains (Losses) | | | | | | Foreign | | on Available | | | | | | Currency | | for Sale | | | | | | Translation | | Securities | | Total | | | | (in thousands) | Balance - December 31, 2019 | | $ | 1,861 | | $ | 33 | | $ | 1,894 | Other comprehensive income (loss) | | | (21) | | | (16) | | | (37) | Balance - September 30, 2020 | | $ | 1,840 | | $ | 17 | | $ | 1,857 |
There were minimal reclassifications from AOCI into net income for the three and nine months ended September 30, 2017.2020 and 2019. For the nine months ended September 30, 2017, Additional Paid-in Capital increased approximately $228.8 million related to 7.2 million shares issued for the Ultratech merger consideration, $47.5 million related to the issuance of the Convertible Senior Notes including deferred tax impact, and $11.4 million related to on-going share-based compensation activities.
Note 8 -— Share-based compensationCompensation Restricted share awards are issued to employees that are subject to specified restrictions and a risk of forfeiture. The restrictions typically lapse over one to five years and may entitle holders to dividends and voting rights. Other types of share-based compensation include performance share awards, performance share units, and restricted share units (collectively with restricted share awards, “restricted shares”), as well as options to purchase common stock. Share-based compensation expense was recognized in the following line items in the Consolidated Statements of Operations for the three and nine months ended September 30, 20172020 and 2016:2019: | | | | | | | | | | | | | | | | | | Three months ended September 30, | | Nine months ended September 30, | | | | | 2020 | | 2019 | | 2020 | | 2019 | | | | Three months ended September 30, | | Nine months ended September 30, | | | | | 2017 | | 2016 | | 2017 | | 2016 | | | | | (in thousands) | | | | | | (in thousands) | | Cost of sales | | $ | 740 | | $ | 607 | | $ | 1,898 | | $ | 1,639 | | | $ | 389 | | $ | 383 | | $ | 1,384 | | $ | 1,448 | | Research and development | | 849 | | 993 | | 1,986 | | 3,032 | | | | 674 | | | 756 | | | 2,161 | | | 2,531 | | Selling, general, and administrative | | 3,714 | | 2,143 | | 10,182 | | 7,462 | | | | 1,879 | | | 2,644 | | | 6,017 | | | 7,549 | | Restructuring | | 867 | | — | | 1,707 | | — | | | Acquisition costs | | — | | — | | 4,203 | | — | | | Total | | $ | 6,170 | | $ | 3,743 | | $ | 19,976 | | $ | 12,133 | | | $ | 2,942 | | $ | 3,783 | | $ | 9,562 | | $ | 11,528 | |
For the nine months ended September 30, 2017,2020, equity activity related to stock options was as follows: | | Number of | | Weighted Average | | | | Shares | | Exercise Price | | | | (in thousands) | | | | | Balance - December 31, 2016 | | 1,576 | | $ | 35.18 | | Granted | | — | | — | | Exercised | | (18 | ) | 30.03 | | Expired or forfeited | | (129 | ) | 37.03 | | Balance - September 30, 2017 | | 1,429 | | 35.07 | |
| | | | | | | | | | Weighted | | | Number of | | Average | | | Shares | | Exercise Price | | | (in thousands) | | | | Balance - December 31, 2019 | | 1,119 | | | 34.88 | Expired or forfeited | | (339) | | | 33.94 | Balance - September 30, 2020 | | 780 | | | 35.28 |
Table of Contents Veeco Instruments Inc. and Subsidiaries Notes to the Consolidated Financial Statements - continued (unaudited) For the nine months ended September 30, 2017,2020, equity activity related to non-vested restricted shares and performance shares was as follows: | | | | Weighted Average | | | | | Number of | | Grant Date | | | | | Shares | | Fair Value | | | | | (in thousands) | | | | | Balance - December 31, 2016 | | 1,949 | | $ | 23.85 | | | | | | | | | | | | | | | Weighted | | | | | | Average | | | | Number of | | Grant Date | | | | Shares | | Fair Value | | | | (in thousands) | | | | Balance - December 31, 2019 | | | 2,257 | | | 16.20 | Granted | | 642 | | 29.35 | | | 1,006 | | | 9.40 | Assumed from Ultratech | | 338 | | 31.75 | | | Performance award adjustments | | | (51) | | | 30.94 | Vested | | (695 | ) | 27.12 | | | (775) | | | 15.97 | Forfeited | | (173 | ) | 26.39 | | | (366) | | | 15.38 | Balance - September 30, 2017 | | 2,061 | | 25.85 | | | | Balance - September 30, 2020 | | | 2,071 | | | 12.76 |
Note 9 -— Income Taxes Income taxes are estimated for each of the jurisdictions in which the Company operates. Deferred income taxes reflect the net tax effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, as well as the tax effect of carryforwards. Realization of net deferred tax assets is dependent on future taxable income. At September 30, 2017,2020, the Company’s U.S. deferred tax assets are fully offset by a valuation allowance since the Company cannot conclude that it is more likely than not that these future benefits will be realized. At the end of each interim reporting period, the effective tax rate is aligned with expectations for the full year. This estimate is used to determine the income tax provision on a year-to-date basis and may change in subsequent interim periods. If necessary, the year-to-date tax benefit for interim period losses is limited to the amount that could be recognizable at the end of the fiscal year. Income (loss) before income taxes and income tax expense (benefit) for the three and nine months ended September 30, 20172020 and 20162019 were as follows: | | | | | | | | | | | | | | | | | | Three months ended September 30, | | Nine months ended September 30, | | | | | 2020 | | 2019 | | 2020 | | 2019 | | | | Three months ended September 30, | | Nine months ended September 30, | | | | | 2017 | | 2016 | | 2017 | | 2016 | | | | | (in thousands) | | | | | | | | | | (in thousands) | | Income (loss) before income taxes | | $ | (23,674 | ) | $ | (68,462 | ) | $ | (64,146 | ) | $ | (114,535 | ) | | $ | 791 | | $ | (11,695) | | $ | (7,760) | | $ | (45,455) | | Income tax expense (benefit) | | $ | (1,790 | ) | $ | 1,136 | | $ | (24,969 | ) | $ | 2,677 | | | $ | 211 | | $ | 72 | | $ | 530 | | $ | 407 | |
The net incomeCompany’s tax benefitexpense for the three months ended September 30, 20172020 was comprised of a net benefit of $2.2$0.2 million relatedcompared to $0.1 million for the Company’s U.S. operations, and a netcomparable prior period. The 2020 tax expense of $0.4included a $0.2 million expense related to the Company’s non-U.S. operations and minimal expense related to the Company’s domestic operations, compared to 2019 when the expense included a $0.1 million expense related to the Company’s domestic operations and minimal expense related to the Company’s non-U.S. operations. The net incomeCompany’s tax benefitexpense for the nine months ended September 30, 20172020 was comprised of$0.5 million, compared to $0.4 million for the comparable prior period. The 2020 tax expense included a net benefit of $21.6$0.2 million and $3.4 millionexpense related to the Company’s U.S.domestic operations and non-U.S. operations, respectively. The net income tax benefit from the Company’s U.S. operations was primarily attributable to a tax benefit of $2.2$0.3 million and $23.5 million for losses incurred during the three and nine months ended September 30, 2017, respectively. Under the intraperiod tax allocation rules, the deferred tax liability created upon the issuance of the Convertible Senior Notes and recorded through Additional Paid-in Capital is treated as a source of income, which enables the Company to recognize a benefit for the U.S. loss before income taxes through operations during fiscal 2017. The tax benefitexpense related to the issuance ofCompany’s non-U.S. operations, compared to 2019 when the Convertible Senior Notes will not recur in future years. This benefit was partially offset byexpense included a deferred provision of approximately $1.9$0.2 million expense related to tax amortization on indefinite-lived intangible assetsdomestic operations and a $0.2 million expense related to non-U.S. operations. Although there was a domestic pre-tax loss for the nine months ended September 30, 2017.
The net income tax benefit of $3.4 million for the nine months ended September 30, 2017, from the Company’s non-U.S. operations was primarily attributable to the Company’s determination in the first quarter of 2017 that it was more likely than not that it will meet the requirements of an existing foreign tax incentive agreement. As a result, the Company remeasured this uncertain tax position2020 and recognized a $6.3 million benefit during the first quarter, which is comprised of a reversal of a $4.9 million tax liability established in previous periods and the recognition of a deferred tax benefit of $1.4 million related to certain foreign net operating losses generated in prior years that are now determined to be realizable. This benefit was partially offset by a current year tax expense of approximately $3.1 million attributed to the profitable non-U.S. operations, of which approximately $0.4 million was recorded during the three months ended September 30, 2017.
For the three and nine months ended September 30, 2016, the Company2019, Veeco did not provide a current tax benefit on U.S.domestic pre-tax losses sinceas the Company couldamounts are not conclude that it is more likely than not that the benefits would be realized.realizable on a more-likely-than-not basis. The current period domestic tax expense is primarily relatedattributable to the tax amortization of indefinite-lived intangible assets that are amortizedis not available to offset U.S. deferred tax assets. The non-U.S. tax expense for the nine months ended September 30, 2020 is primarily attributable to tax purposes but not for financial reporting purposes, as well as taxes attributedexpense on non-U.S. operation profits and foreign
Table of Contents Veeco Instruments Inc. and Subsidiaries Notes to the profitable non-U.S. operations. The deferredConsolidated Financial Statements - continued (unaudited) withholding taxes on unremitted earnings as of September 30, 2020, offset by a tax liability created bybenefit related to the tax deductible expense cannot be used to offset existing deferred taxamortization of intangible assets. Note 10 -— Segment Reporting and Geographic Information Veeco operates and measures its results in one1 operating segment and continues to do so with the integration of Ultratech’s business activities. As a result, the Companytherefore has one1 reportable segment: the design, development, manufacture, and support of semiconductorthin film process equipment primarily sold to make electronic devices.
Veeco categorizes its revenue bysales into the key markets into which it sells. As a resultfollowing 4 end-markets: Front-End Semiconductor Front-End Semiconductor refers to the early steps in the process of integrated circuit fabrication where the acquisition of Ultratech,microchips are created but still remain on the Company’s four key markets are now: silicon wafer. This category includes Laser Spike Anneal, Ion Beam etch for front-end semiconductor applications, and Ion Beam deposition for EUV mask blanks. LED Lighting, Display & Compound Semiconductor (formerly Lighting, Display & Power Electronics); Advanced Packaging, MEMS & RF; Scientific & Industrial, which now includes Data Storage, which was formerly a separate category; and Front-End Semiconductor, which was formerly included in the Scientific & Industrial market category. LED Lighting, Display & Compound Semiconductor
LED Lighting refers to Light Emitting Diode (“LED”) and semiconductor illumination sources used in various applications including, but not limited to, displays such as backlights, general lighting, automotive running lights, and headlamps. Display refers to LEDs used for displays and Organic Light Emitting Diode (“OLED”) displays found in outdoor display/signage applications, TVs, smartphones, wearable devices, and tablets. Compound Semiconductor includes Photonics, Power Electronics, and Radio Frequency (“RF”) Devices. Photonics refers to laser diodes, Vertical Cavity Surface Emitting Lasers (“VCSEL”) in 3D sensing and communications, and various other optical devices. Power Electronics refers to semiconductor devices such as rectifiers, inverters, and converters for the control and conversion of electric power. RF devices refers to radio frequency emitting and receiving devices that enable wireless communications. Such devices include power amplifiers, switches, and transceivers for applications such as mobile (including handsets and base stations), defense, automotive,automobile, and the internetInternet of things.Things. Advanced Packaging, MEMS & RF Filters
Advanced Packaging includes a portfolio of wafer-level assembly technologies that enable the miniaturization and performance improvement of electronic products, such as smartphones, smartwatches, tablets, and laptops. Micro-Electro Mechanical Systems (“MEMS”) includes tiny mechanical devices such as sensors, switches, mirrors, and actuators embedded in semiconductor chips used in vehicles, smartphones, tablets, and games. RF Filters refers to RF filters used in smartphones, tablets, and mobile devices.
Scientific & Industrial Scientific refers to advanced materials research at university research institutions, industry research institutions, industry consortiums, and government research agencies. Industrial refers to large-scale product manufacturing applications including data storage and optical coatings: thin layers of material deposited on a lens or mirror that alters how light reflects and transmits. Front-End SemiconductorAdvanced Packaging, MEMS & RF Filters
Front-End SemiconductorAdvanced Packaging includes a portfolio of wafer-level assembly technologies that enable improved performance of electronic products, such as smartphones, high-end servers, and graphical processors. Micro-Electro Mechanical Systems (“MEMS”) includes tiny mechanical devices such as sensors, switches, mirrors, and actuators embedded in semiconductor chips used in vehicles, smartphones, tablets, and games. RF Filters refers to RF filters used in smartphones, tablets, and mobile devices.
Table of Contents Veeco Instruments Inc. and Subsidiaries Notes to the early steps in the process of integrated circuit fabrication where the microchips are created but still remain on the silicon wafer. This category includes Laser Spike Anneal, Ion Beam etch for front-end semiconductor applications, and Ion Beam deposition for EUV mask blanks.Consolidated Financial Statements - continued (unaudited) Sales by end-market and geographic region for the three and nine months ended September 30, 20172020 and 20162019 were as follows: | | Three months ended September 30, | | Nine months ended September 30, | | | | 2017 | | 2016 | | 2017 | | 2016 | | | | (in thousands) | | Sales by end-market | | | | | | | | | | LED Lighting, Display & Compound Semiconductor | | $ | 59,721 | | $ | 49,427 | | $ | 170,546 | | $ | 97,985 | | Advanced Packaging, MEMS & RF | | 22,775 | | 12,092 | | 55,756 | | 52,400 | | Scientific & Industrial | | 33,145 | | 20,997 | | 86,917 | | 82,726 | | Front-End Semiconductor | | 16,231 | | 2,966 | | 28,105 | | 5,731 | | Total | | $ | 131,872 | | $ | 85,482 | | $ | 341,324 | | $ | 238,842 | | Sales by geographic region | | | | | | | | | | United States | | $ | 34,723 | | $ | 19,104 | | $ | 73,256 | | $ | 66,550 | | China | | 15,197 | | 21,238 | | 81,811 | | 54,621 | | EMEA(1) | | 17,243 | | 19,703 | | 57,312 | | 61,999 | | Rest of World | | 64,709 | | 25,437 | | 128,945 | | 55,672 | | Total | | $ | 131,872 | | $ | 85,482 | | $ | 341,324 | | $ | 238,842 | |
| | | | | | | | | | | | | | | | Three months ended September 30, | | Nine months ended September 30, | | | | 2020 | | 2019 | | 2020 | | 2019 | | | | | (in thousands) | | Sales by end-market | | | | | | | | | | | | | | Front-End Semiconductor | | $ | 20,789 | | $ | 33,578 | | $ | 69,914 | | $ | 80,703 | | LED Lighting, Display & Compound Semiconductor | | | 20,098 | | | 24,020 | | | 51,516 | | | 47,263 | | Scientific & Industrial | | | 52,479 | | | 39,975 | | | 145,033 | | | 127,230 | | Advanced Packaging, MEMS & RF Filters | | | 18,712 | | | 11,381 | | | 48,753 | | | 50,951 | | Total | | $ | 112,078 | | $ | 108,954 | | $ | 315,216 | | $ | 306,147 | | Sales by geographic region | | | | | | | | | | | | | | United States | | $ | 39,602 | | $ | 27,915 | | $ | 108,869 | | $ | 100,014 | | China | | | 10,464 | | | 17,034 | | | 38,328 | | | 46,846 | | EMEA(1) | | | 14,991 | | | 19,128 | | | 57,271 | | | 49,280 | | Rest of World | | | 47,021 | | | 44,877 | | | 110,748 | | | 110,007 | | Total | | $ | 112,078 | | $ | 108,954 | | $ | 315,216 | | $ | 306,147 | |
(1) | EMEA consists of Europe, the Middle East, and Africa |
(1) EMEA consists of Europe, the Middle East, and Africa
For geographic reporting, sales are attributed to the location in which the customer facility is located. Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations Cautionary Statement Regarding Forward Looking Statements Our discussion below constitutescontains “forward-looking statements” within the meaning of Section 27Athe safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1933,1995, as amended, that are based on management’s expectations, estimates, projections and Section 21E of the Securities Exchange Act of 1934,assumptions. Words such as amended. When used in this Report, the words “believes,“expects,” “anticipates,” “expects,” “estimates,” “targets,” “plans,” “intends,“believes,” “will,“scheduled,” “estimates” and variations of these words and similar expressions related to the future are intended to identify forward-looking statements. All forward-lookingForward-looking statements in this discussion include, but are not limited to, those regarding anticipated growth and trends in our businesses and markets, industry outlooks and demand drivers, our investment and growth strategies, our development of new products and technologies, our business outlook for the current and future periods, the impact of the COVID-19 pandemic and the affects thereof on our operations and financial results, and other statements that are not historical facts. These statements and their underlying assumptions are subject to a number of risks and uncertainties and are not guarantees of future performance. Factors that could cause actual results to differ materially from projected results. You shouldthose expressed or implied by such statements include, without limitation: the level of demand for our products; global economic and industry conditions; the effects of regional or global health epidemics, including the effects of the COVID-19 pandemic on the Company’s operations and on those of our customers and suppliers; global trade issues, including the ongoing trade disputes between the U.S. and China, and changes in trade and export license policies; our dependency on third-party outsourcing partners; the timing of customer orders; our ability to develop, deliver and support new products and technologies; our ability to expand our current markets, increase market share and develop new markets; the concentrated nature of our customer base; our ability to obtain and protect intellectual property rights in key technologies; our ability to achieve the objectives of operational and strategic initiatives and attract, motivate and retain key employees; the variability of results among products and segments, and our ability to accurately forecast future results, market conditions, and customer requirements; the impact of our indebtedness, including our convertible senior notes and our capped call transactions; and other risks and uncertainties described in our SEC filings on Forms 10-K, 10-Q and 8-K. All forward-looking statements speak only to management’s expectations, estimates, projections and assumptions as of the date of this filing or, in the case of any document referenced herein or incorporated by reference, the date of that document. The Company does not place undue reliance onundertake any obligation to update or publicly revise any forward-looking statements which speak only as of the dates they are made. Executive Summary
On May 26, 2017, we completed the acquisition of Ultratech. Ultratech designs, manufactures, and markets lithography, laser annealing, and inspection equipment for manufacturers of semiconductor devices, including front-end semiconductor manufacturing and advanced packaging. Ultratech also designs, manufactures, and markets atomic layer deposition (“ALD”) equipment for scientific and industrial applications. Ultratech’s customers are primarily located throughout the United States, EMEA, China, Japan, Taiwan, Singapore, and Korea. The results of Ultratech’s operations have been includedto reflect events, circumstances or changes in the consolidated financial statements sinceexpectations after the date of acquisition.this filing.
Executive Summary Together with Ultratech, we design, manufacture, and market
We are an innovative manufacturer of semiconductor process equipment aligned to meet the demands of key global trends such as energy conservation, mobility, and connectivity.equipment. Our MOCVD, lithography,proven ion beam, laser annealing, ion beam,lithography, MOCVD and single wafer etch and& clean technologies play an integral role in producing LEDs for solid-state lightingthe fabrication and displays and in the fabricationpackaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, we holdVeeco holds leading technology leadership positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com. COVID-19 Update As a result of the COVID-19 pandemic, governmental authorities have implemented and are continuing to implement numerous and constantly evolving measures to try to contain the virus, such as travel bans and restrictions, limits on gatherings, quarantines, shelter-in-place orders, and business shutdowns. We have important manufacturing operations in the U.S. and sales and support operations in China, Germany, Japan, Malaysia, Philippines, Singapore, South Korea, Thailand, Taiwan and the United Kingdom, all of which have been affected by the COVID-19 pandemic. Measures providing for business shutdowns generally exclude certain essential services, and those essential services include critical infrastructure and the businesses that support that critical infrastructure. Our operations are considered part of the critical and essential infrastructure defined by applicable government authorities, and, although governmental measures to contain the pandemic may be modified or extended, our manufacturing facilities remain open. We believe our diverse product offerings and the critical nature of certain of our products for infrastructure insulate us, to some extent, from the adverse effects of the pandemic; however, a prolonged economic downturn will adversely affect our customers, which could have a material adverse effect on our revenues, particularly if customers from whom we derive a significant amount of revenue reduce or delay purchases to mitigate the impacts of the pandemic or fail to make payments to us on time or at all. We serve a global and highly interconnected customer base across the Asia-Pacific region, Europe, and North America. Our net sales to customers located outside of the United States represented approximately 70%, 77%, and 80% of our total net sales in 2019, 2018, and 2017, respectively, and we expect that net sales to customers outside the United States will continue to represent a significant percentage of our total net sales. As a result, our business will be adversely impacted by further deterioration in global economic conditions, particularly in markets in Asia and Europe. To date, we have not yet experienced any significant interruptions to our supply chain as a result of the COVID-19 pandemic. We continue to monitor our global supply chain and may experience disruptions in future periods, primarily as a result of financial challenges confronting companies in our supply chain and restrictions or disruptions of transportation, such as reduced availability of air transport, port closures and increased border controls or closures, any of which could cause a disruption in our ability to obtain raw materials or components required to manufacture our products. Like many in our industry, we are managing through the effects of the COVID-19 pandemic. Although the full extent of the COVID-19 pandemic’s impact on our business, results of operations, supply chains and growth can not be predicted or quantified, we proactively identified potential challenges to our business and have been executing business continuity activities to manage disruptions in our business and continue to provide critical infrastructure to our customers. In response to the pandemic, we have taken, or intend to take, the following steps, among others, to keep our employees safe and minimize the spread of the virus, while continuing to serve our customers: | ● | implemented rigorous health and safety protocols at our manufacturing facilities, including extensively and frequently disinfecting our facilities, limiting access to our facilities, checking temperatures of individuals entering our facilities, staggering shifts to minimize employee overlap in gowning areas, and providing protective equipment; |
| ● | mandated remote working arrangements for employees that do not need to be physically present on the manufacturing floor or at customer facilities; |
| ● | implemented virtual meetings, customer demos, and factory acceptances to enable customers to review data and performance of their system in our factory remotely via live video; |
| ● | performing service and support activities remotely to resolve customer issues and enable our customers to maintain their operations; |
| ● | proactively identified gaps in our supply chain and re-sourced a number of components in order to maintain our customer shipment commitments and mitigate single points of failure; |
| ● | monitoring our IT systems and implementing contingency and disaster recovery plans to support our IT infrastructure to ensure that our systems remain continuously operative; and |
| ● | continuing to monitor and, if necessary, reduce our operating expenses and capital expenditures to maintain financial flexibility and profit margins. |
While these served markets.steps have been effective so far, there could be additional challenges ahead that may impact either our operations or those of our customers, which could have a negative effect on our financial performance, including productivity and capacity impacts as a result of the ongoing pandemic. We expect to continue to implement these measures until we determine that the COVID-19 pandemic is adequately contained for purposes of our business, and we may take further actions as government authorities require or recommend or as we determine to be in the best interests of our employees, customers and suppliers. As a result, we may incur additional expenses in future periods in response to the pandemic, which could adversely affect our financial position, results of operations, or cash flows. In addition, we may revise our approach to these initiatives or take additional actions to meet the needs of our employees and customers, and mitigate the impact of the pandemic on our business. Business Update We categorize our revenue by the key marketsmarket segments into which we sell. Our four key markets are: Front-End Semiconductor; LED Lighting, Display & Compound Semiconductor; Advanced Packaging, MEMS & RF; Scientific & Industrial; and Front-End Semiconductor. Sales in the LED Lighting, Display & Compound Semiconductor market were driven by the continued shipment of MOCVD and PSP systems to customers in Europe, China, and Southeast Asia, along with a large MBE system shipment in the Solar application space. The largest applications for LEDs are solid state lighting, followed by TV displays. Over the past few quarters, demand has increased for larger LCD TV displays, which require relatively more LEDs to backlight than smaller display sizes. We have also seen an increase in LED demand for fine-pitch digital signage. These trends have driven an increase in demand for our MOCVD equipment and build-up in our MOCVD backlog. Our broad portfolio of MOCVD technologies has been developed to support the most significant industry trends, including developing mid-power LEDs, utilizing larger wafer sizes, and optimizing cost-of-ownership. Our TurboDisc® EPIK™ 700 GaN MOCVD system continues to win new business for blue LEDs. Our TurboDisc K475i™ AsP MOCVD system targets red-orange-yellow LEDs, laser diodes, and high-efficiency triple junction photovoltaic solar cells and continues to gain market momentum. During the quarter we released our latest MOCVD system, the EPIK868, offering a lower cost and higher productivity solution for our customers. The EPIK868 was designed to meet the needs of our customers in China, demonstrating our long-term commitment to this region. We believe that the expected profits from increased revenues may be partially offset by lower margins based on the current competitive environment.
Sales in the Advanced Packaging, MEMS & RF markets continue to be influenced by the mobility trend and increasing functionality in mobile devices and were driven by Ultratech and PSP sales in Advanced Packaging and continued PSP sales for MEMs and RF Filter applications. Sales into the Advanced Packaging market have slowed, largely tied to large Lithography system purchases in 2016 and early 2017, combined with delays in FOWLP (Fan Out Wafer Level Packaging) adoption by some smartphone manufacturers and weak smartphone sales. We remain well positioned for growth as FOWLP and other advance packaging applications grow over the longer term. Our versatile PSP product architecture has allowed us to continue to generate solid business in the MEMs and RF Filter portion of this category.Filters.
Sales in the Scientific & Industrial markets were supported by shipments of AD&E systems for optical coatings and data storage applications, as well as shipments of MBE systems to universities and laboratories. While equipment demand from
each individual market may fluctuate quarter to quarter, the diverse customer base has historically provided a relatively stable revenue stream for the company on a combined basis.
Sales in the Front-End Semiconductor market were driven by shipment of our Ion Beam Deposition system for EUV Mask Blank manufacturing. In the EUV market, customers appear to be moving ahead with their leading node EUV lithography plans for logic and memory applications, continuing to drive requirements for our mask blank systems. Looking ahead, we continue to work with our customers with our laser annealing technology, and seek additional customers, as they develop their “next nodes”. We believe demand for these two product lines, driven by the development and release of advanced node semiconductors, will continue to provide future growth opportunities for us. Sales in the LED Lighting, Display & Compound Semiconductor market grew sequentially in the third quarter. We shipped MOCVD and PSP systems in the quarter for compound semiconductor applications in Photonics, Power Electronics, and RF devices. Additionally, we received acceptance of our Lumina MOCVD beta system which was under evaluation at one of our top customers. During the evaluation period, this Arsenide Phosphide MOCVD system passed rigorous testing and was qualified for production of several advanced photonics devices. We have a broad portfolio of MOCVD and PSP technologies which have been developed to support emerging applications such as 5G driven RF device manufacturing, photonics devices including 3D sensing laser diodes and mini/microLEDs, and GaN-based power electronics. We continue to work with customers to penetrate these markets. Sales in the Scientific & Industrial market were primarily driven by Ultratech’s Laser Annealingshipments of Ion Beam systems for data storage applications. Demand for our Ion Beam products for Data Storage is being driven by big data and AD&E’s Photomask systems.cloud-based storage growth. In order to be successful, hard disk drive manufacturers are required to improve areal density of magnetic heads for hard disk drives and are manufacturing drives with an increasing number of thin film magnetic heads. These two factors taken together, along with new innovations by HDD manufacturers such as heat assisted magnetic recording and microwave assisted magnetic recording, are driving additional capacity requirements and equipment upgrades. Additionally, recent trends in the work from home environment and the importance of cloud computing are also providing tailwinds to this market. We have good visibility in this market, which gives us confidence it will remain healthy through 2021. Sales in the Advanced Packaging, MEMS and RF Filter market were driven by shipments of lithography systems for Advanced Packaging as well as wet etch & clean systems for Advanced Packaging and RF filter manufacturing. We expect the RF Filter market to remain strong in the near term driven by 5G requirements for higher filter content in mobile devices. Global trade policies have recently become more restrictive, resulting in increased tensions, which have impacted and may continue to impact our business. The U.S. government has implemented controls over transactions involving Chinese entities, and possibly others, who may respond by developing their own solutions or utilize our foreign competitors to replace our products. We have previously seen evidence of this behavior in transactions across our product lines, including our MOCVD and Wet Etch & Clean products. Our revenue from customers in China, which may be impacted if customers continue this behavior, represents a small percentage of our overall revenue. Overall, the Data Storage market, the RF Filter market, and the Front-End Semiconductor market are all performing well for us today, and we expect these markets to provide growth in the near term, through 2021. Long term growth for 2022 and beyond is expected to come from the Front-End Semiconductor and Compound Semiconductor markets. As such, we have been making strategic investments in R&D and inventory, including evaluation systems, in these markets, as well as improving our service capabilities to support these anticipated growth opportunities. Results of Operations For the three months ended September 30, 20172020 and 20162019 The following table presents revenue and expense line items reported in our Consolidated Statements of Operations for 20172020 and 20162019 and the period-over-period dollar and percentage changes for those line items. Our results of operations are reported as one business segment, represented by our single operating segment, including the Ultratech business acquired.segment. | | Three months ended September 30, | | Change | | | | 2017 | | 2016 | | Period to Period | | | | (dollars in thousands) | | Net sales | | $ | 131,872 | | 100% | | $ | 85,482 | | 100% | | $ | 46,390 | | 54% | | Cost of sales | | 78,811 | | 60% | | 52,027 | | 61% | | 26,784 | | 51% | | Gross profit | | 53,061 | | 40% | | 33,455 | | 39% | | 19,606 | | 59% | | Operating expenses, net: | | | | | | | | | | | | | | Research and development | | 24,061 | | 18% | | 19,892 | | 23% | | 4,169 | | 21% | | Selling, general, and administrative | | 29,771 | | 23% | | 18,396 | | 22% | | 11,375 | | 62% | | Amortization | | 12,500 | | 9% | | 5,261 | | 6% | | 7,239 | | 138% | | Restructuring | | 5,010 | | 4% | | 1,798 | | 2% | | 3,212 | | 179% | | Acquisition costs | | 783 | | 1% | | — | | 0% | | 783 | | * | | Asset impairment | | 2 | | 0% | | 56,035 | | 66% | | (56,033 | ) | (100)% | | Other, net | | (140 | ) | (0)% | | 795 | | 1% | | (935 | ) | (118)% | | Total operating expenses, net | | 71,987 | | 55% | | 102,177 | | 120% | | (30,190 | ) | (30)% | | Operating income (loss) | | (18,926 | ) | (14)% | | (68,722 | ) | (80)% | | 49,796 | | * | | Interest income (expense), net | | (4,748 | ) | (4)% | | 260 | | 0% | | (5,008 | ) | * | | Income (loss) before income taxes | | (23,674 | ) | (18)% | | (68,462 | ) | (80)% | | 44,788 | | * | | Income tax expense (benefit) | | (1,790 | ) | (1)% | | 1,136 | | 1% | | (2,926 | ) | * | | Net income (loss) | | $ | (21,884 | ) | (17)% | | $ | (69,598 | ) | (81)% | | $ | 47,714 | | * | |
| | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | | Change | | | | 2020 | | | 2019 | | | Period to Period | | | | | (dollars in thousands) | | Net sales | | $ | 112,078 | | 100% | | | $ | 108,954 | | 100% | | | $ | 3,124 | | 3% | | | Cost of sales | | | 62,936 | | 56% | | | | 66,731 | | 61% | | | | (3,795) | | (6)% | | | Gross profit | | | 49,142 | | 44% | | | | 42,223 | | 39% | | | | 6,919 | | 16% | | | Operating expenses, net: | | | | | | | | | | | | | | | | | | | | Research and development | | | 19,129 | | 17% | | | | 22,639 | | 21% | | | | (3,510) | | (16)% | | | Selling, general, and administrative | | | 19,415 | | 17% | | | | 20,962 | | 19% | | | | (1,547) | | (7)% | | | Amortization of intangible assets | | | 3,831 | | 3% | | | | 4,312 | | 4% | | | | (481) | | (11)% | | | Restructuring | | | — | | - | | | | 1,828 | | 2% | | | | (1,828) | | * | | | Other operating expense (income), net | | | (218) | | - | | | | (153) | | - | | | | (65) | | 42% | | | Total operating expenses, net | | | 42,157 | | 38% | | | | 49,588 | | 46% | | | | (7,431) | | (15)% | | | Operating income (loss) | | | 6,985 | | 6% | | | | (7,365) | | (7)% | | | | 14,350 | | 195% | | | Interest income (expense), net | | | (6,194) | | (6)% | | | | (4,330) | | (4)% | | | | (1,864) | | 43% | | | Income (loss) before income taxes | | | 791 | | 1% | | | | (11,695) | | (11)% | | | | 12,486 | | 107% | | | Income tax expense (benefit) | | | 211 | | - | | | | 72 | | - | | | | 139 | | * | | | Net income (loss) | | $ | 580 | | 1% | | | $ | (11,767) | | (11)% | | | $ | 12,347 | | 105% | | |
* Not meaningful | Not meaningful |
Net Sales The following is an analysis of sales by market and by region: | | Three months ended September 30, | | Change | | | | 2017 | | 2016 | | Period to Period | | | | (dollars in thousands) | | Sales by market | | | | | | | | | | | | | | LED Lighting, Display & Compound Semiconductor | | $ | 59,721 | | 45% | | $ | 49,427 | | 58% | | $ | 10,294 | | 21% | | Advanced Packaging, MEMS & RF | | 22,775 | | 17% | | 12,092 | | 14% | | 10,683 | | 88% | | Scientific & Industrial | | 33,145 | | 25% | | 20,997 | | 25% | | 12,148 | | 58% | | Front-End Semiconductor | | 16,231 | | 13% | | 2,966 | | 3% | | 13,265 | | 447% | | Total | | $ | 131,872 | | 100% | | $ | 85,482 | | 100% | | $ | 46,390 | | 54% | | Sales by geographic region | | | | | | | | | | | | | | United States | | $ | 34,723 | | 26% | | $ | 19,104 | | 22% | | $ | 15,619 | | 82% | | China | | 15,197 | | 12% | | 21,238 | | 25% | | (6,041 | ) | (28)% | | EMEA | | 17,243 | | 13% | | 19,703 | | 23% | | (2,460 | ) | (12)% | | Rest of World | | 64,709 | | 49% | | 25,437 | | 30% | | 39,272 | | 154% | | Total | | $ | 131,872 | | 100% | | $ | 85,482 | | 100% | | $ | 46,390 | | 54% | |
| | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | | Change | | | | | 2020 | | | 2019 | | | Period to Period | | | | | | (dollars in thousands) | | | Sales by market | | | | | | | | | | | | | | | | | | | | Front-End Semiconductor | | $ | 20,789 | | 18% | | | $ | 33,578 | | 31% | | | $ | (12,789) | | (38)% | | | LED Lighting, Display & Compound Semiconductor | | | 20,098 | | 18% | | | | 24,020 | | 22% | | | | (3,922) | | (16)% | | | Scientific & Industrial | | | 52,479 | | 47% | | | | 39,975 | | 37% | | | | 12,504 | | 31% | | | Advanced Packaging, MEMS & RF Filters | | | 18,712 | | 17% | | | | 11,381 | | 10% | | | | 7,331 | | 64% | | | Total | | $ | 112,078 | | 100% | | | $ | 108,954 | | 100% | | | $ | 3,124 | | 3% | | | Sales by geographic region | | | | | | | | | | | | | | | | | | | | United States | | $ | 39,602 | | 36% | | | $ | 27,915 | | 25% | | | $ | 11,687 | | 42% | | | China | | | 10,464 | | 9% | | | | 17,034 | | 16% | | | | (6,570) | | (39)% | | | EMEA | | | 14,991 | | 13% | | | | 19,128 | | 18% | | | | (4,137) | | (22)% | | | Rest of World | | | 47,021 | | 42% | | | | 44,877 | | 41% | | | | 2,144 | | 5% | | | Total | | $ | 112,078 | | 100% | | | $ | 108,954 | | 100% | | | $ | 3,124 | | 3% | | |
Total sales
Sales increased across all market categoriesslightly for the three months ended September 30, 20172020 against the comparable prior year period in the Scientific & Industrial and Advanced Packaging, MEMS & RF Filters markets, partially offset by decreases in the Front-End Semiconductor and LED Lighting, Display & Compound Semiconductor markets. Sales in the Scientific & Industrial market were primarily driven by ongoing improvements in LED industry conditions, as well as additional sales from the Ultratech business acquired in May 2017, spread across all markets.shipments of Ion Beam systems to data storage customers. Pricing was not a significant driver of the change in total sales. By geography, sales increased in the United States and Rest of World regions, partially offset by decreases in the China and EMEA. The most significant increase occurred in the Rest of World region, which was attributable to the increased sales in the LED Lighting, Display & Compound Semiconductor market in Malaysia, as well as additional sales from the Ultratech business acquired. Additionally, increased sales in the United States were primarily attributable to increased sales in the Scientific & Industrial market, as well as additional sales from the Ultratech business acquired.EMEA regions. We expect there will continue to be year-to-year variations in our future sales distribution across markets and geographies. Orders increased to $161.9 million for In light of the three months ended September 30, 2017 from $118.0 million for the comparable prior year period. The increase in orders was primarily attributable to increasesglobal nature of our business, we are impacted by conditions in the LED Lighting, Display & Compound Semiconductorvarious countries in which we and Scientific & Industrialour customers operate. Several markets including additional bookingscontinue to remain challenged in light of ongoing restrictions on business and travel, and decreased business and consumer spending generally, resulting from the Ultratech acquisition.COVID-19 pandemic.
One of the performance measures we use as a leading indicator of the business is the book-to-bill ratio. The ratio is defined as orders recorded in a given period divided by revenue recognized in the same period. A ratio greater than one indicates we are adding orders faster than we are recognizing revenue. Gross Profit
For the three months ended September 30, 2017, the ratio was 1.2, compared to 1.4 for the comparable prior period. Our backlog at September 30, 2017 was $299.2 million, which was higher than the backlog at June 30, 2017 of $269.5 million. During the three months ended September 30, 2017, we recorded backlog adjustments of approximately $0.1 million relating to orders that no longer met our bookings criteria. Gross Profit
In the third quarter of 2017,2020, gross profit increased compared to the third quarter of 2016 due to a sharp increase in sales volume, including the acquisition of Ultratech. Gross margins remained relatively consistent for the three months ended September 30, 2017 against the comparable prior period as theprimarily due to an increase in sales volume and increased gross margins. Gross margins increased principally due to higher production activity, as well as reductions in inventory reserves and warranty expenses. We expect our gross margins to fluctuate each period due to product mix and region mix of sales in the period was offset by an inventory fair value step-up that was recorded in connection with the purchase accounting relating to the Ultratech acquisition. Given the current competitive environment in MOCVD business, we may see a decline in gross margins as we move beyond this calendar year.other factors.
Research and developmentDevelopment The markets we serve are characterized by continuous technological development and product innovation, and we invest in various research and development initiatives to maintain our competitive advantage and achieve our growth objectives. Research and development expenses increased indecreased for the third quarter of 2017 comparedthree months ended September 30, 2020 against the comparable prior period primarily due to the third quarter of 2016 primarily as a result of the addition of the acquired Ultratech related research and development projects, partially offset by our decision to significantly reduce investments in certain technology, as well as decreases in other personnel-related expenses and professional fees as a result of our initiative to streamline operations, enhance efficiency, and reduce costs. In the second half of 2019, we executed an initiative to reorganize various functions along product lines and created a central research and development organization to better allocate our resources to our highest priority projects. Additionally, we had a decrease in travel-related expenses as a result of COVID-19 related restrictions. Selling, general,General, and administrativeAdministrative Selling, general, and administrative expenses increaseddecreased for the three months ended September 30, 2020 against the comparable prior period primarily due to the addition of the acquired Ultratech related selling, general and administrative costs,personnel-related expenses as well as increased professional and legal fees. Amortization expense
The increase in amortization expense is a result of the additional intangibles acquired as part of the acquisition of Ultratech, offset by the lower amortization resulting from the impairment of the certain technology assets in the prior year as well as certain other intangible assets becoming fully amortized during 2016.
Restructuring expense
During 2016, we undertook restructuring activities as part of our initiative to streamline operations, enhance efficiency, and reduce costs. Additionally, we had a decrease in travel-related expenses as a result of COVID-19 related restrictions. Given the the uncertainty regarding the impacts on our business resulting from the COVID-19 pandemic, we are focused on the proactive management of expenses. In future periods, we may incur additional selling, general and administrative expenses to support our responses to the COVID-19 pandemic.
Amortization Expense Amortization expense decreased compared to prior period primarily due to the sale of a non-core product line, including related intangible assets, as well as changes in amortization expense to reflect expected cash flows of certain intangible assets. Restructuring Expense We recorded restructuring charges during the year ended December 31, 2019 as a result of our efforts to further streamline operations, enhance efficiencies, and reduce costs, as well as reducing future investments in certain technologycosts. In the second half of 2019, we executed an initiative to reorganize various functions along product lines and created a central research and development which together impacted approximately 75 employees.organization to better allocate our resources to our highest priority projects. In addition, during 2017, we begandelayered the acquisition integration process to enhance efficiencies, resulting in additional employee terminations and other facility closing costs. Over the next few quarters, we expect to incur additional restructuring costs of $1 million to $5 million as it finalizes all oforganization. Collectively, these activities.
Acquisition costs
Acquisition costs are non-recurring charges incurred in connection with the acquisition of the Ultratech business.
Asset Impairment
actions impacted approximately 60 employees. During the third quarter of 2016 we decided to significantly reduce investments in certain technologies and recorded non-cash asset impairment charges of $57.6 million, partially offset by an adjustment to our assessment of the fair market value of an asset then held as available-for-sale of $1.6 million. Interest Income (Expense)
For the three months ended September 30, 2017, we2020, payments were made related to these previous restructuring initiatives, while no additional charges were incurred.
Interest Income (Expense) We recorded net interest expense of $4.7$6.2 million for the three months ended September 30, 2020, compared with net interest income of $0.3to $4.3 million infor the comparable prior year period. The changeincrease in interest expense was primarily relatesrelated to the Convertible Seniorissuance of the 2027 Notes issued in January 2017.May 2020, partially offset by the partial repurchase of the 2023 Notes. Included in interest expense for the three months ended September 30, 2020 were non-cash charges of $3.5 million related to the amortization of debt discount and transaction costs of the 2023 and 2027 Notes, while the three months ended September 30, 2019 included non-cash charges of $3.2 million related to the amortization of debt discount and transaction costs of the 2023 Notes. Additionally, interest income decreased approximately $1.0 million for the three months ended September 30, 2020 compared to the prior period, primarily as a result of lower interest rates, and we expect interest income to remain depressed as a result. Income Taxes At the end of each interim reporting period, we estimate the effective income tax rate expected to be applicable for the full year. This estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim periods. OurWe incurred a tax benefitexpense of $0.2 million for the three months ended September 30, 2017 was $1.8 million2020 compared to a tax expense of $1.1$0.1 million for the comparable prior period. The 20172020 tax benefitexpense included a $2.2an expense of $0.2 million benefit relatingrelated to our non-US operations and minimal expense related to our domestic operations, and a $0.4 million expense relating to our non-U.S. operations, compared to 20162019 when ourthe expense included $0.3 million relatedwas mainly attributable to domestic operations and $0.8 million related to our non-U.S. operations. The current period domestic tax benefit is primarily attributable to an income tax benefit for losses incurred during the three months ended September 30, 2017, as the deferred tax liability created by the issuance
Results of the Convertible Senior Notes is treated as a source of income in fiscal 2017, offset by a deferred provision related to tax amortization on indefinite-lived intangible assets. The current period non-U.S. tax expense is attributable to the profitable non-U.S. operations. The tax expense for the comparable period is primarily attributable to the tax amortization of indefinite-lived intangible assets that is not available to offset U.S. deferred tax assets.Operations For the nine months ended September 30, 20172020 and 20162019 The following table presents operating results as a percentagerevenue and expense line items reported in our Consolidated Statements of net sales, as well asOperations for 2020 and 2019 and the period-over-period dollar and percentage changes for those line items. Our results | | | | | | | | | | | | | | | | | | | | | Nine Months Ended September 30, | | | Change | | | 2020 | | | 2019 | | | Period to Period | | | | (dollars in thousands) | Net sales | | $ | 315,216 | | 100% | | | $ | 306,147 | | 100% | | | $ | 9,069 | | 3% | | Cost of sales | | | 177,761 | | 56% | | | | 192,924 | | 63% | | | | (15,163) | | (8)% | | Gross profit | | | 137,455 | | 44% | | | | 113,223 | | 37% | | | | 24,232 | | 21% | | Operating expenses, net: | | | | | | | | | | | | | | | | | | | Research and development | | | 57,577 | | 18% | | | | 68,901 | | 23% | | | | (11,324) | | (16)% | | Selling, general, and administrative | | | 55,541 | | 18% | | | | 60,620 | | 20% | | | | (5,079) | | (8)% | | Amortization of intangible assets | | | 11,502 | | 4% | | | | 12,773 | | 4% | | | | (1,271) | | (10)% | | Restructuring | | | 1,097 | | - | | | | 3,874 | | 1% | | | | (2,777) | | (72)% | | Asset impairment | | | 281 | | - | | | | — | | - | | | | 281 | | * | | Other operating expense (income), net | | | (502) | | - | | | | (232) | | - | | | | (270) | | 116% | | Total operating expenses, net | | | 125,496 | | 40% | | | | 145,936 | | 48% | | | | (20,440) | | (14)% | | Operating income (loss) | | | 11,959 | | 4% | | | | (32,713) | | (11)% | | | | 44,672 | | 137% | | Interest income (expense), net | | | (16,673) | | (5)% | | | | (12,742) | | (4)% | | | | (3,931) | | 31% | | Loss on extinguishment of debt | | | (3,046) | | (1)% | | | | — | | - | | | | (3,046) | | * | | Income (loss) before income taxes | | | (7,760) | | (2)% | | | | (45,455) | | (15)% | | | | 37,695 | | 83% | | Income tax expense (benefit) | | | 530 | | - | | | | 407 | | - | | | | 123 | | 30% | | Net income (loss) | | $ | (8,290) | | (3)% | | | $ | (45,862) | | (15)% | | | $ | 37,572 | | 82% | |
Table of operations are reported as one business segment, including the Ultratech business acquired.Contents | | Nine months ended September 30, | | Change | | | | 2017 | | 2016 | | Period to Period | | | | (dollars in thousands) | | Net sales | | $ | 341,324 | | 100% | | $ | 238,842 | | 100% | | $ | 102,482 | | 43% | | Cost of sales | | 215,344 | | 63% | | 141,991 | | 59% | | 73,353 | | 52% | | Gross profit | | 125,980 | | 37% | | 96,851 | | 41% | | 29,129 | | 30% | | Operating expenses, net | | | | | | | | | | | | | | Research and development | | 57,669 | | 17% | | 63,545 | | 27% | | (5,876 | ) | (9)% | | Selling, general, and administrative | | 71,574 | | 21% | | 58,230 | | 24% | | 13,344 | | 23% | | Amortization | | 21,722 | | 6% | | 15,785 | | 7% | | 5,937 | | 38% | | Restructuring | | 9,605 | | 3% | | 3,993 | | 2% | | 5,612 | | 141% | | Acquisition costs | | 16,277 | | 5% | | — | | 0% | | 16,277 | | * | | Asset impairment | | 1,139 | | 0% | | 69,662 | | 29% | | (68,523 | ) | (98)% | | Other, net | | (228 | ) | (0)% | | 884 | | 0% | | (1,112 | ) | (126)% | | Total operating expenses, net | | 177,758 | | 52% | | 212,099 | | 89% | | (34,341 | ) | (16)% | | Operating income (loss) | | (51,778 | ) | (15)% | | (115,248 | ) | (48)% | | 63,470 | | * | | Interest income (expense), net | | (12,369 | ) | (4)% | | 713 | | 0% | | (13,082 | ) | * | | Income (loss) before income taxes | | (64,146 | ) | (19)% | | (114,535 | ) | (48)% | | 50,389 | | * | | Income tax expense (benefit) | | (24,969 | ) | (7)% | | 2,677 | | 1% | | (27,646 | ) | * | | Net income (loss) | | $ | (39,177 | ) | (11)% | | $ | (117,212 | ) | (49)% | | $ | 78,035 | | * | |
* Not Meaningful
Net Sales The following is an analysis of sales by market and by region: | | | | | | | | | | | | | | | | | | | | Nine Months Ended September 30, | | Change | | | | 2020 | | 2019 | | Period to Period | | | Nine months ended September 30, | | Change | | | | | 2017 | | 2016 | | Period to Period | | | | | (dollars in thousands) | | | | | | (dollars in thousands) | Sales by market | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Front-End Semiconductor | | | $ | 69,914 | | 22% | | $ | 80,703 | | 26% | | $ | (10,789) | | (13)% | LED Lighting, Display & Compound Semiconductor | | $ | 170,546 | | 51% | | $ | 97,132 | | 41% | | $ | 73,414 | | 76% | | | | 51,516 | | 16% | | | 47,263 | | 15% | | | 4,253 | | 9% | Advanced Packaging, MEMS & RF | | 55,756 | | 16% | | 52,400 | | 22% | | 3,356 | | 6% | | | Scientific & Industrial | | 86,917 | | 25% | | 83,510 | | 35% | | 3,407 | | 4% | | | | 145,033 | | 46% | | | 127,230 | | 42% | | | 17,803 | | 14% | Front-End Semiconductor | | 28,105 | | 8% | | 5,800 | | 2% | | 22,305 | | 385% | | | Advanced Packaging, MEMS & RF Filters | | | | 48,753 | | 16% | | | 50,951 | | 17% | | | (2,198) | | (4)% | Total | | $ | 341,324 | | 100% | | $ | 238,842 | | 100% | | $ | 102,482 | | 43% | | | $ | 315,216 | | 100% | | $ | 306,147 | | 100% | | $ | 9,069 | | 3% | Sales by geographic region | | | | | | | | | | | | | | | | | | | | | | | | | | | | | United States | | $ | 73,256 | | 21% | | $ | 66,550 | | 28% | | $ | 6,706 | | 10% | | | $ | 108,869 | | 35% | | $ | 100,014 | | 33% | | $ | 8,855 | | 9% | China | | 81,811 | | 24% | | 54,621 | | 23% | | 27,190 | | 50% | | | | 38,328 | | 12% | | | 46,846 | | 15% | | | (8,518) | | (18)% | EMEA | | 57,312 | | 17% | | 61,999 | | 26% | | (4,687 | ) | (8)% | | | | 57,271 | | 18% | | | 49,280 | | 16% | | �� | | 7,991 | | 16% | Rest of World | | 128,945 | | 38% | | 55,672 | | 23% | | 73,273 | | 132% | | | | 110,748 | | 35% | | | 110,007 | | 36% | | | 741 | | 1% | Total | | $ | 341,324 | | 100% | | $ | 238,842 | | 100% | | $ | 102,482 | | 43% | | | $ | 315,216 | | 100% | | $ | 306,147 | | 100% | | $ | 9,069 | | 3% |
Total salesSales increased across all market categories for the nine months ended September 30, 20172020 against the comparable prior year period in the Scientific & Industrial and LED Lighting, Display & Compound Semiconductor markets, partially offset by decreases in the Front-End Semiconductor and Advanced Packaging, MEMS & RF Filters markets. Sales in the Scientific & Industrial market were primarily driven by ongoing improvements in LED industry conditions, as well as additional sales from the Ultratech business acquired in May 2017, spread across all markets.shipments of Ion Beam systems to data storage customers. Pricing was not a significant driver of the change in total sales. Sales alsoBy geography, sales increased across most geographical regions, primarily due to the increased sales in the LED Lighting, Display & Compound Semiconductor market, as well as additional sales from the Ultratech acquisition. Increased sales in theUnited States, EMEA, and Rest of World region was principally drivenregions, partially offset by a significant increasedecreases in sales to customers located in Malaysia.China. We expect there will continue to be year-to-year variations in our future sales distribution across markets and geographies. In light of the global nature of our business, we are impacted by conditions in the various countries in which we and our customers operate. Several markets continue to remain challenged in light of ongoing restrictions on business and travel, and decreased business and consumer spending generally, resulting from the COVID-19 pandemic.
Orders increased to $391.9 million for the nine months ended September 30, 2017 from $247.3 million for the comparable prior year period. The increase in orders was primarily attributable to an increase of over 80% in orders in the LED Lighting, Display, & Compound Semiconductor market, as well as a 41% increase in the Scientific & Industrial market.
One of the performance measures we use as a leading indicator of the business is the book-to-bill ratio. The ratio is defined as orders recorded in a given period divided by revenue recognized in the same period. A ratio greater than one indicates we are adding orders faster than we are recognizing revenue. For the nine months ended September 30, 2017 and September 30, 2016, the ratio was 1.1. Our backlog at September 30, 2017 was $299.2 million, which was higher than the backlog at December 31, 2016 of $209.2 million. During the nine months ended September 30, 2017, we increased backlog by approximately $41.6 million relating to backlog acquired from Ultratech, while adjusting for a decrease in backlog of approximately $1.7 million relating to orders that no longer met our bookings criteria.
Gross Profit For the nine months ended September 30, 2017,2020, gross profit increased compared to 2016against the comparable prior period primarily due to a sharpan increase in sales volume including the addition of the Ultratech acquisition, partially offset by decreasedand increased gross margins. Gross margins decreasedincreased principally due to an inventory fair value step-up that was recorded in connection with the purchase accounting relating to the Ultratech acquisitionhigher production activity, as well as productreductions in inventory reserves and region mix of sales in the period. Given the current competitive environment in MOCVD business, we may see a decline inwarranty expenses. We expect our gross margins as we move beyond this calendar year.to fluctuate each period due to product mix and other factors. Research and developmentDevelopment The markets we serve are characterized by continuous technological development and product innovation, and we invest in various research and development initiatives to maintain our competitive advantage and achieve our growth objectives. Research and development expenses decreased for the nine months ended September 30, 2017 compared2020 against the comparable prior period primarily due to 2016 primarily as a result of our decision to significantly reduce investments in certain technology, as well as decreases in other personnel-related expenses and professional fees as a result of our initiative to streamline operations, enhance efficiency, and reduce costs. These decreases were partially offset byIn the additionsecond half of the acquired Ultratech related2019, we executed an initiative to reorganize various functions along product lines and created a central research and development organization to better allocate our resources to our highest priority projects. Additionally, we had a decrease in travel-related expenses as a result of COVID-19 related restrictions. Selling, general,General, and administrativeAdministrative Selling, general, and administrative expenses increaseddecreased for the nine months ended September 30, 2017 compared to 20162020 against the comparable prior period primarily due to the addition of the acquired Ultratech related selling, general and administrative costs. Amortization expense
The increase in amortization expense ispersonnel-related expenses as a result of the additional intangibles acquired as part of the acquisition of Ultratech, offset by the lower amortization resulting from the impairment of certain technology assets in the prior year as well as certain other intangible assets becoming fully amortized during 2016.
Restructuring expense
During 2016, we undertook restructuring activities as part of our initiative to streamline operations, enhance efficiency, and reduce costs. Additionally, we had a decrease in travel-related expenses as a result of COVID-19
related restrictions. Given the the uncertainty regarding the impacts on our business resulting from the COVID-19 pandemic, we are focused on the proactive management of expenses. In future periods, we may incur additional selling, general and administrative expenses to support our responses to the COVID-19 pandemic. Amortization Expense Amortization expense decreased compared to prior period primarily due to the sale of a non-core product line, including related intangible assets, as well as changes in amortization expense to reflect expected cash flows of certain intangible assets. Restructuring Expense We continued to record restructuring charges during the year ended December 31, 2019 as a result of our efforts to further streamline operations, enhance efficiencies, and reduce costs, as well as reducing future investments in certain technologycosts. In the second half of 2019, we executed an initiative to reorganize various functions along product lines and created a central research and development which togetherorganization to better allocate our resources to our highest priority projects. In addition, we delayered the organization. Collectively, these actions impacted approximately 7560 employees. In addition, during 2017, we beganDuring the acquisition integration processnine months ended September 30, 2020, additional accruals were recognized and payments were made related to enhance efficiencies, resulting in additional employee terminations and other facility closing costs. Over the next few quarters, we expect to incur additionalthese restructuring costs of $1 million to $5 million as it finalizes all of these activities.initiatives. Acquisition costsInterest Income (Expense)
Acquisition costs are non-recurring charges incurred in connection with the acquisitionWe recorded net interest expense of the Ultratech business, which included $4.2$16.7 million on non-cash charges related to accelerated share-based compensation for employee terminations for the nine months ended September 30, 2017.
Asset Impairment2020, compared to $12.7 million for the comparable prior year period. The increase in interest expense
During was primarily related to the nine months ended September 30, 2016, we recorded non-cash impairment charges of $57.6 million relating to our decision to significantly reduce investments in certain technologies, $5.9 million relating to our assessmentsissuance of the fair market value2027 Notes in May 2020, partially offset by the partial repurchase of assets held for sale, and $6.1 million relating to the disposal of certain lab equipment. Impairment charges2023 Notes. Included in interest expense for the nine months ended September 30, 2017 primarily relate2020 were non-cash charges of $10.3 million related to assessmentsthe amortization of debt discount and transaction costs of the fair market value of assets held for sale.
Interest Income (Expense)
For2023 and 2027 Notes, while the nine months ended September 30, 2017, we recorded net interest expense2019 included non-cash charges of $12.4$9.4 million compared with netrelated to the amortization of debt discount and transaction costs of the 2023 Notes. Additionally, interest income decreased approximately $2.3 million for the nine months ended September 30, 2020 compared to the prior period, primarily as a result of $0.7lower interest rates, and we expect interest income to remain depressed as a result.
Loss on Extinguishment of Debt On May 18, 2020, in connection with the completion of a private offering of $125 million aggregate principal amount of 3.75% convertible senior notes described below, we repurchased and retired approximately $88.3 million in aggregate principal amount of our outstanding 2023 Notes, with a carrying amount of $78.1 million, for approximately $81.2 million of cash. We accounted for the repurchase of the $88.3 million of the 2023 Notes as an extinguishment, and as such, recorded a loss on extinguishment of approximately $3.0 million in the prior year period. The change primarily relates to the Convertible Senior Notes issued in January 2017.second quarter of 2020. Income Taxes At the end of each interim reporting period, we estimate the effective income tax rate expected to be applicable for the full year. This estimate is used to determine the income tax provision or benefit on a year-to-date basis and may change in subsequent interim periods. Our tax benefitexpense for the nine months ended September 30, 20172020 was $25.0$0.5 million compared to a tax expense of $2.7$0.4 million for the comparable prior period. The 20172020 tax benefitexpense included $21.6an expense of $0.2 million relatingrelated to our domestic operations, and $3.4$0.3 million relatingrelated to our non-U.S. operations, compared to 20162019 when ourthe expense included $1.2a $0.2 million expense related to our domestic operations and $1.5a $0.2 million expense related to our non-U.S. operations. The current periodAlthough there was a domestic tax benefit is primarily attributable to an income tax benefitpre-tax loss for losses incurred during the nine months ended September 30, 2017,2020 and 2019, we did not provide a current tax benefit on domestic pre-tax losses as the deferred tax liability created by the issuance of the Convertible Senior Notes is treated asamounts are not realizable on a source of income in fiscal 2017, offset by a deferred provision related to tax amortization on indefinite-lived intangible assets.more-likely-than-not basis. The current period non-U.S. tax benefit is primarily attributable to the remeasurement of an uncertain tax position, which included the reversal of a previously established non-U.S. tax liability and the recognition of a deferred tax benefit related to certain foreign net operating losses generated in prior years that are now determined to be realizable, offset by tax expense attributed to the profitable non-U.S. operations. Thedomestic tax expense for the comparablecurrent period is primarily attributable to the tax amortization of indefinite-lived intangible assets that is not available to offset U.S. deferred tax assets. The current period non-U.S. tax expense is primarily attributable to tax expense on non-U.S. operation profits and foreign withholding taxes on unremitted earnings as of September 30, 2020, offset by a tax benefit related to the amortization of intangible assets. Liquidity and Capital Resources Our cash and cash equivalents, restricted cash, and short-term investments and restricted cash are as follows: | | | | | | | | | | | September 30, | | December 31, | | | | 2020 | | 2019 | | | September 30, | | December 31, | | | | | 2017 | | 2016 | | | | | (in thousands) | | | | | | (in thousands) | Cash and cash equivalents | | $ | 235,268 | | $ | 277,444 | | | $ | 147,588 | | $ | 129,294 | Restricted cash | | | | 664 | | | 657 | Short-term investments | | 85,853 | | 66,787 | | | | 161,585 | | | 115,252 | Total | | $ | 321,121 | | $ | 344,231 | | | $ | 309,837 | | $ | 245,203 |
A portion of our cash and cash equivalents is held by our subsidiaries throughout the world, frequently in each subsidiary’s respective functional currency, which is typically the U.S. dollar. At September 30, 20172020 and December 31, 2016,2019, cash and cash equivalents of $194.7$41.7 million and $149.2$73.0 million, respectively, were held outside the United States. In order to fund continued international growth, it isAs of September 30, 2020, we had $12.8 million of accumulated undistributed earnings generated by our current intention to permanently reinvestnon-U.S. subsidiaries for which the cashU.S. repatriation tax has been provided and cash equivalent balances held in China, Taiwan, and Malaysia, and our current forecasts dodid not require repatriationthe use of these fundscash due to the use of net operating loss carryforwards. Approximately $5.8 million of undistributed earnings will be subject to foreign withholding taxes if distributed back to the United States. At September 30, 2017, we had $143.9 million in cash held outside the United States on which we may have to pay significant U.S. income taxes to repatriate or utilize net operating loss carryforwards. Additionally, local government regulations may restrict our ability to move cash balances under certain circumstances. We currently do not expect such regulations and restrictions to impact our ability to make acquisitions, pay vendors, or conduct operations.
We believe that our projected cash flow from operations, combined with our cash and short term short-term investments, will be sufficient to meet our projected working capital requirements, contractual obligations, and other cash flow needs for the next twelve months, including the scheduled interest payments on our Convertible Senior Notes issuedconvertible senior notes, purchase commitments and payments in January 2017.respect of operating leases. However, the COVID-19 pandemic, together with other dynamics in the marketplace, has resulted in wider credit spreads and significantly increased borrowing costs and, in certain cases, limited the ability of companies to access the capital markets and other sources of financing on attractive terms or at all. Although there is uncertainty related to the anticipated impact of the recent COVID-19 outbreak on our future results, we believe our business model, our current cash and short-term investments and the recent steps we have taken to rationalize expenses, leave us well-positioned to manage our business through this crisis as it continues to unfold. A summary of the cash flow activity atfor the nine months ended September 30, 20172020 and 20162019 is as follows: | | | | | | | | | | Nine Months Ended September 30, | | | | 2020 | | 2019 | | | | | (in thousands) | | Net income (loss) | | $ | (8,290) | | $ | (45,862) | | Non-cash items: | | | | | | | | Depreciation and amortization | | | 23,021 | | | 25,838 | | Non-cash interest expense | | | 10,282 | | | 9,418 | | Deferred income taxes | | | 330 | | | 20 | | Share-based compensation expense | | | 9,562 | | | 11,528 | | Loss on extinguishment of debt | | | 3,046 | | | — | | Asset impairment | | | 281 | | | — | | Provision for bad debts | | | 140 | | | — | | Changes in operating assets and liabilities | | | (10,781) | | | (23,947) | | Net cash provided by (used in) operating activities | | $ | 27,591 | | $ | (23,005) | |
Cash Flows from Operating Activities
| | Nine months ended September 30, | | | | 2017 | | 2016 | | | | (in thousands) | | Net income (loss) | | $ | (39,177 | ) | $ | (117,212 | ) | Non-cash items: | | | | | | Depreciation and amortization | | 32,295 | | 26,010 | | Non-cash interest expense | | 7,641 | | — | | Deferred income taxes | | (21,235 | ) | 1,529 | | Share-based compensation expense | | 19,976 | | 12,133 | | Asset impairment | | 1,139 | | 69,662 | | Provision for bad debts | | 99 | | 160 | | Changes in operating assets and liabilities | | 14,538 | | (16,590 | ) | Net cash provided by (used in) operating activities | | $ | 15,276 | | $ | (24,308 | ) |
Net cash provided by operating activities was $15.3$27.6 million for the nine months ended September 30, 20172020 and was due to the net loss of $39.2$8.3 million plus adjustments for non-cash items of $39.9 million, offset by an increaseand a decrease in cash flow from operating activities due to changes in operating assets and liabilities of $14.5$10.8 million, offset by adjustments for non-cash items of $46.7 million. The changes in operating assets and liabilities were largely attributable to increases in accounts receivable and inventories, partially offset by increases in accounts payable and customer deposits. Cash Flows from Investing Activities | | | | | | | | | | | | Nine Months Ended September 30, | | | | | 2020 | | 2019 | | | | Nine months ended September 30, | | | | | 2017 | | 2016 | | | | | (in thousands) | | | Acquisitions of businesses, net of cash acquired | | $ | (399,478 | ) | $ | — | | | | | | (in thousands) | | Capital expenditures | | (17,403 | ) | (10,717 | ) | | $ | (3,331) | | $ | (8,189) | | Changes in investments, net | | 27,812 | | 52,921 | | | | (46,045) | | | (46,434) | | Other | | 2,284 | | 463 | | | Proceeds from held for sale assets, net of costs to sell | | | | 9,503 | | | 645 | | Net cash provided by (used in) investing activities | | $ | (386,785 | ) | $ | 42,667 | | | $ | (39,873) | | $ | (53,978) | |
The net cash used in investing activities during the nine months ended September 30, 20172020 was primarily attributable to net purchases of investments, partially offset by the net cash used in the acquisitionproceeds from sale of Ultratech as well as capital expenditures. As part of our efforts to streamline operations, enhance efficiency, and reduce costs, we are making certain investments in our facilities to support the consolidation activities, and, in 2017, we expect to incur future capital expenditures related to these activities of approximately $2 million to $5 million.a non-core product line. Cash Flows from Financing Activities | | Nine months ended September 30, | | | | 2017 | | 2016 | | | | (in thousands) | | Settlement of equity awards, net of withholding taxes | | $ | (5,251 | ) | $ | 8 | | Purchases of common stock | | — | | (13,349 | ) | Proceeds from long-term debt borrowings | | 335,752 | | — | | Repayments of long-term debt | | (1,193 | ) | (252 | ) | Net cash provided by (used in) financing activities | | $ | 329,308 | | $ | (13,593 | ) |
| | | | | | | | | | Nine Months Ended September 30, | | | | 2020 | | 2019 | | | | | (in thousands) | | Proceeds from issuance of 2027 Notes, net of issuance costs | | $ | 121,946 | | $ | — | | Purchase of capped calls | | | (10,313) | | | — | | Repurchase of 2023 Notes | | | (81,240) | | | — | | Settlement of equity awards, net of withholding taxes | | | 211 | | | (162) | | Net cash provided by (used in) financing activities | | $ | 30,604 | | $ | (162) | |
The cash provided by financing activities for the nine months ended September 30, 20172020 was primarily related to the net cash proceeds received from the issuance of the 2027 Notes, partially offset by the cash used to repurchase the 2023 Notes as well as the purchase of the capped call transactions. Convertible Senior Notes in January 2017. The cash used in financing activities for the nine months ended September 30, 2016 was primarily related to the share repurchase program, which commenced in November 2015. There were no share repurchases in 2017. Convertible Senior Notes
On January 10, 2017, we issued $345.0 million of 2.70% convertible senior unsecured notes due (the “Convertible Senior“2023 Notes”). We received net proceeds, after deducting underwriting discounts and fees and expenses payable by the Company,us, of approximately $335.8 million. The Convertible Senior2023 Notes bear interest at a rate of 2.70% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing on July 15, 2017. The Convertible Senior2023 Notes mature on January 15, 2023, unless earlier purchased by the Company,us, redeemed, or converted. On May 18, 2020, in connection with the completion of a private offering of $125 million aggregate principal amount of 3.75% convertible senior notes described below, we repurchased and retired approximately $88.3 million in aggregate principal amount of our outstanding 2023 Notes, with a carrying amount of $78.1 million, for approximately $81.2 million of cash. On May 18, 2020, we issued $125.0 million of 3.75% convertible senior notes (the “2027 Notes”). We received net proceeds of approximately $121.9 million, after deducting underwriting discounts and fees and expenses payable by us. Additionally, we used approximately $10.3 million of cash to purchase the capped calls. The 2027 Notes bear interest at a rate of 3.75% per year, payable semiannually in arrears on June 1 and December 1 of each year, commencing on December 1, 2020. The 2027 Notes mature on June 1, 2027, unless earlier purchased by us, redeemed, or converted. We believe that we have sufficient capital resources and cash flows from operations to support scheduled interest payments on this debt.the 2023 and 2027 Notes. Business Combination
As discussed above, on May 26, 2017, the Company acquired 100% of Ultratech, Inc., a leading supplier of lithography, laser-processing, and inspection systems used to manufacture semiconductor devices and LEDs. The results of Ultratech’s operations have been included in the consolidated financial statements since the date of acquisition.
Contractual Obligations and Commitments We have commitments under certain contractual arrangements to make future payments for goods and services. These contractual arrangements secure the rights to various assets and services to be used in the future in the normal course of business. We expect to fund these contractual arrangements with cash generated from operations in the normal course of business. Off-Balance Sheet Arrangements We do not have any off-balance sheet arrangements that have, or are reasonably likely to have, a current or future material effect on our financial condition, changes in financial condition, expenses, and results of operations, liquidity, capital expenditures or capital resources other than operating leases, bank guarantees and purchase commitments disclosed in the preceding footnotes. Item 3. Quantitative and Qualitative Disclosures about Market Risk Interest Rate Risk Our exposure to market rate risk for changes in interest rates primarily relates to our investment portfolio. We centrally manage our investment portfolios considering investment opportunities and risks, tax consequences, and overall financing strategies. Our investment portfolio includes fixed-income securities with a fair value of approximately $85.9$161.6 million at September 30, 2017.2020. These securities are subject to interest rate risk and, based on our investment portfolio at September 30, 2017,2020, a 100 basis point increase in interest rates would result in a decrease in the fair value of the portfolio of $0.2$0.9 million. While an increase in interest rates may reduce the fair value of the investment portfolio, we will not realize the losses in the Consolidated Statements of Operations unless the individual fixed-income securities are sold prior to recovery or the loss is determined to be other-than-temporary. Currency Exchange Risk We conduct business on a worldwide basis and, as such, a portion of our revenues, earnings, and net investments in foreign affiliates is exposed to changes in currency exchange rates. The economic impact of currency exchange rate movements is complex because such changes are often linked to variability in real growth, inflation, interest rates, governmental actions, and other factors. These changes, if material, could cause us to adjust our financing and operating strategies. Consequently, isolating the effect of changes in currency does not incorporate these other important economic factors. FromChanges in currency exchange rates could affect our foreign currency denominated monetary assets and liabilities and forecasted cash flows. We enter into monthly forward derivative contracts from time to time we manage our risks and exposures to currency exchange rates throughwith the useintent of derivative financial instruments (e.g., forward contracts).mitigating a portion of this risk. We mainlyonly use derivative financial instruments in the context of hedging and generally do not use them for speculative purposes. During the third quarter of 2017, wepurposes and had an immaterial amount ofnot designated our foreign exchange derivatives designated as hedges. Accordingly, most foreign exchange derivatives are recorded in our Consolidated Balance Sheets at fair value and changes in fair value from these contracts are recorded inas “Other, net” in our Consolidated Statements of Operations. We execute derivative transactions with highly rated financial institutions to mitigate counterparty risk.
Our net sales to customers located outside of the United States represented approximately 74%64% and 79%65% of our total net sales for the three and nine months ended September 30, 2017,2020, respectively, and 78%75% and 72%67% for the comparable 20162019 periods. We expect that net sales to customers outside the United States will continue to represent a large percentage of our total net sales. Our sales denominated in currencies other than the U.S. dollar represented 1%7% and 2%5% of total net sales in the three and nine months ended September 30, 2017,2020, respectively, and 2%3% and 4% for the comparable 20162019 periods. A 10% change in foreign exchange rates would have an immaterial impact on the consolidated results of operations since most of our sales outside the United States are denominated in U.S. dollars. Item 4. Controls and Procedures Management’s Report on Internal Control overOver Financial Reporting Our principal executive and financial officers have evaluated and concluded that our disclosure controls and procedures are effective as of September 30, 2017.2020. The disclosure controls and procedures are designed to ensure that the information required to be disclosed in this report filed under the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to our principal executive and financial officers as appropriate to allow timely decisions regarding required disclosure. Changes in Internal Control overOver Financial Reporting On May 26, 2017, we completed the acquisition of Ultratech, Inc., and are integrating the acquired business into our overall internal control over financial reporting process. Management is in the process of assessing the internal control over financial reporting and is implementing or revising internal controls where necessary. See Note 3 to the Consolidated Financial
Statements — Business Combinations, for further details. There were no other changes in internal control forDuring the quarter ended September 30, 20172020, there were no changes in internal control that have materially affected or are reasonably likely to materially affect internal control over financial reporting.
PART II—OTHER INFORMATION Item 1. Legal Proceedings On September 21, 2017, Blueblade Capital Opportunities LLCJune 8, 2018, an Ultratech shareholder who received Veeco stock as part of the consideration for the Ultratech acquisition filed a purported class action complaint in the Superior Court of the State of California, County of Santa Clara, captioned Wolther v. Maheshwari et al., Case No. 18CV329690, on behalf of purported beneficial owners of 440,100himself and others who purchased or acquired shares of Veeco pursuant to the registration statement and prospectus which Veeco filed with the SEC in connection with the Ultratech common stock,acquisition (the “Wolther Action”). On August 2 and August 8, 2018, two purported class action complaints substantially similar to the Wolther Action were filed an action against Ultratechon behalf of different plaintiffs in Delaware Court of Chancery requesting an appraisalthe same court as the Wolther Action. These cases have been consolidated with the Wolther Action, and a consolidated complaint was filed on December 11, 2018. The consolidated complaint seeks to recover damages and fees under Sections 11, 12, and 15 of the valueSecurities Act of their Ultratech stock pursuant to 8 Del. C. §262. The Company believes that the merger price, which was the product of arms-length negotiations, was fair and reasonable, and intends to contest the appraisal claim. Discovery1933 for, among other things, alleged false/misleading statements in the matter has commenced. On April 12, 2017, the Company filed a patent infringement complaint in the U.S. District Court for the Eastern District of New York against SGL Carbon, LLCregistration statement and SGL Carbon SE (collectively, “SGL”), alleging infringement of patents relating to wafer carrier technology used in MOCVD equipment. The complaint alleges that SGL infringes Veeco’s patents by making and selling certain wafer carriers to Veeco’s competitor, Advanced Micro-Fabrication Equipment, Inc. (“AMEC”). On November 2, 2017, the U.S. District Court granted the Company’s motion for a preliminary injunction prohibiting SGL from shipping wafer carriers using the Company’s patented technology without the Company’s express authorization. The Company continues to seek a post-trial permanent injunction and monetary damages against SGL.
On July 13, 2017, AMEC filed a patent infringement complaint against Veeco Instruments Shanghai Co., Ltd. (“Veeco Shanghai”) with the Fujian High Court in China, alleging that the Company’s MOCVD products infringed a Chinese utility model patentprospectus relating to the synchronous movement engagement mechanismUltratech acquisition, relating primarily to the alleged failure to disclose delays in the advanced packaging business, increased MOCVD competition in China, and an intellectual property dispute. Veeco is defending this matter vigorously.
On December 21, 2018, a chemical vapor deposition reactor and seeking injunctive relief and monetary damages againstpurported Veeco Shanghai. The Company believes this complaint is without merit and intends to vigorously defend against these allegations. The Company hasstockholder filed a petition for invalidation of this patent withderivative action in the Chinese Patent Reexamination Board (“PRB”). The Fujian HighSuperior Court has suspended the infringement case against Veeco pending the outcome of the invalidation proceeding atState of California, County of Santa Clara, captioned Vladimir Gusinsky Revocable Trust v. Peeler, et al., Case No. 18CV339925, on behalf of nominal defendant Veeco. The complaint seeks to assert claims for breach of fiduciary duty, waste of corporate assets, and unjust enrichment against current and former Veeco directors premised on purported misstatements and omissions in the PRB.registration statement relating to the Ultratech acquisition. Veeco is defending this matter vigorously. The Company is involved in various other legal proceedings arising in the normal course of business. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its consolidated financial position, results of operations, or cash flows. Item 1A. Risk Factors Information regarding risk factors appears in the Safe Harbor Statement at the beginning of this quarterly report on Form 10-Q, and in Part I — Item 1A of our 20162019 Form 10-K,. and Part 2, Item 1A of our quarterly reports on Form 10-Q for the quarters ending March 31, 2020 and June 30, 2020. There have been no material changes from the risk factors previously disclosed in our 2016 Form 10-K.disclosed. Item 2. Unregistered Sales of Equity Securities and Use of Proceeds None. On October 28, 2015, our Board of Directors authorized a program to repurchase up to $100 million of our common stock to be completed through October 28, 2017. At September 30, 2017, $22.3 million of the $100 million had been utilized. No repurchases occurred after the first quarter of 2016. Repurchases may be made from time to time on the open market or in privately negotiated transactions in accordance with applicable federal securities laws. The timing and amount of future repurchases, if any, will depend upon market conditions, SEC regulations, and other factors. The repurchases would be funded using available cash balances and cash generated from operations. The program does not obligate us to acquire any particular amount of common stock and may be modified or suspended at any time at our discretion.
Item 3. Defaults uponUpon Senior Securities None. Item 4. Mine Safety Disclosures Not Applicable. Item 5. Other Information None. Item 6. Exhibits Unless otherwise indicated, each of the following exhibits has been filed with the Securities and Exchange Commission by Veeco under File No. 0-16244.
*104
| | Filed herewithCover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
| | | | | | | | ** | | | | | | | | | | | | | | | | | | | | | | | **
| | Filed herewith electronically
| | | | | | | | | | | | | | | | | | | |
* Filed herewith ** Filed herewith electronically SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on November 3, 2017.October 27, 2020. | | | | Veeco Instruments Inc. | | | | | | | By: | /S/ JOHN R. PEELERWILLIAM J. MILLER, Ph.D. | | | | John R. PeelerWilliam J. Miller, Ph.D.
| | |
|
| Chairman and Chief Executive Officer
| | |
| | | | By: | /s/ SHUBHAM MAHESHWARIJOHN P. KIERNAN | | | | Shubham MaheshwariJohn P. Kiernan
| | |
|
| ExecutiveSenior Vice President and Chief Financial Officer
|
40
|